| Term 
 
        | Initial therapy for most patients with RA? |  | Definition 
 
        | Methotrexate (Rheumatrex) or leflunomide (Arava) |  | 
        |  | 
        
        | Term 
 
        | _______ plus ______ for moderate-to-high RA. |  | Definition 
 
        | Methotrexate 
 hydroxychloroquine (Plaquenil)
 |  | 
        |  | 
        
        | Term 
 
        | _______ plus ________ plus ________ for patients with poor prognostic features and moderate-to-high levels of disease activity. |  | Definition 
 
        | Methotrexate 
 hydroxychloroquine
 
 sulfasalazine (Azulfidine)
 |  | 
        |  | 
        
        | Term 
 
        | The ______ DMARDs ______ and ______ should be reserved for patients with at least moderate disease activity and poor disease prognosis who were not helped by ______ and other ______ DMARDs. |  | Definition 
 
        | biologic DMARDs abatacept (Orencia)and rituximab (Rituxan) 
 methotrexate and other nonbiologic DMARDs
 |  | 
        |  | 
        
        | Term 
 
        | ______ are the new treatment of choice for spondylitis. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | ______ used to treat sacroiliitis |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Sjorgren's Syndrome treatment: _____ |  | Definition 
 
        | Artificial Tears Artificial Saliva
 Vaginal Lubricant
 Avoid anticholinergic medications
 Treat systemic manifestations with anti inflammatory or immunosuppressive agents
 |  | 
        |  | 
        
        | Term 
 
        | RA is characterized by ________. |  | Definition 
 
        | Symmetrical inflammatory polyarthritis |  | 
        |  | 
        
        | Term 
 
        | In RA _______ forms at the interface between synovium and the bone and cartilage |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Initially in RA _____ cells release _____ and ______, which cause synovial cells to release inflammatory mediators. |  | Definition 
 
        | interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-a) |  | 
        |  | 
        
        | Term 
 
        | Radiographic characteristic of RA is inflamed _______ and _____ cartilage. |  | Definition 
 
        | synovial membrane 
 pitted cartilage
 |  | 
        |  | 
        
        | Term 
 
        | The histologic features of the rheumatoid nodule (RA) are irregular zones of ______ surrounded by epithelioid cells (histiocytes) and chronic inflammatory cells. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The histologic features of the rheumatoid nodule are irregular zones of fibrinoid necrosis surrounded by epithelioid cells (histiocytes) and chronic inflammatory cells. The epithelioid cells are frequently _______ around the necrotic zone. |  | Definition 
 
        | palisaded (Olden time log fence) |  | 
        |  | 
        
        | Term 
 
        | RA: un/symmetrical ____arthritis. |  | Definition 
 
        | symmetrical polyarthritis |  | 
        |  | 
        
        | Term 
 
        | Morning stiffness in RA lasts _____ as opposed to morning stiffness with osteoarthritis that lasts _____. |  | Definition 
 
        | More than one hours 
 few minutes
 |  | 
        |  | 
        
        | Term 
 
        | Late stage RA Joint destruction: _______. |  | Definition 
 
        | Boutonniere deformity of thumb 
 ulnar deviation of MP
 
 Swan Neck Fingers
 |  | 
        |  | 
        
        | Term 
 
        | RA Systemic features: RA ______ can occur anywhere. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | RA Systemic features: _____ and _____ syndrome. |  | Definition 
 
        | Caplan’s Syndrome 
 Felty’s Syndrome
 |  | 
        |  | 
        
        | Term 
 
        | Caplan’s Syndrome in RA, there are ______ nodules. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Felty’s Syndrom: in RA is characterized by ______ and _____ with recurrent _____ infections. |  | Definition 
 
        | splenomegaly & leukopenia with recurrent pulmonary infections |  | 
        |  | 
        
        | Term 
 
        | RA Clinical Diagnosis: ___________. |  | Definition 
 
        | Symmetrical synovitis of small joints: warm, swollen joints with synovial hypertrophy, morning stiffness and fatigue are the classic feature. |  | 
        |  | 
        
        | Term 
 
        | For patients with early RA (less than 3 months), ________ (along with ______) should be reserved only for patients with high disease activity who have never received DMARDs. |  | Definition 
 
        | anti-tumor necrosis factor (anti-TNF) biologic drugs (along with methotrexate) |  | 
        |  | 
        
        | Term 
 
        | For longer duration RA, _______ are recommended for patients who have not been helped by methotrexate. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The three approved anti-TNF DMARDs are: ____________ |  | Definition 
 
        | etanercept (Enbrel) infliximab (Remicade)
 adalimumab (Humira).
 |  | 
        |  | 
        
        | Term 
 
        | Types of Spondyloarthropathies: |  | Definition 
 
        | Ankylosing Spondylitis Reactive Arthritis
 Inflammatory Bowel Disease
 Psoriatic Arthritis
 |  | 
        |  | 
        
        | Term 
 
        | Spondyloarthropathy is any joint disease of the vertebral column. WIKI |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Sacroilitis is inflammation of the ________, which Spondylitis is inflammation of the ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Enthesitis is inflammation of the ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Uveitis is inflammation of the ______ and is considered an _______. |  | Definition 
 
        | anterior chamber of the eye 
 medical emergency
 |  | 
        |  | 
        
        | Term 
 
        | The Spondyloarthropathies: Sacroiliitis, spondylitis, Enthesitis, and Uveitis all vary in their ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | _____ is most associated with HLA-B27. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Ankylosing Spondylitis is characterized by: ________. |  | Definition 
 
        | Sacroiliitis 5+ Spondylitis 4+
 Peripheral Arthritis 1+
 |  | 
        |  | 
        
        | Term 
 
        | _________ is the new treatment of choice for Ankylosing Spondylitis. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Following Ankylosing Spondylitis, _______ is has the second most association with HLA-B27. |  | Definition 
 
        | Posturethral Reactive Arthritis |  | 
        |  | 
        
        | Term 
 
        | Posturethral Reactive Arthritis is characterized by: ________ and involvement of _______. |  | Definition 
 
        | Sacroiliitis 3+ Spondylitis 3+
 Peripheral arthritis 4+
 
 Eye, GU, GI and heart
 |  | 
        |  | 
        
        | Term 
 
        | Posturethral Reactive Arthritis is commonly triggered by ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Postdysenteric Reactive Arthritis is characterized by _______ and involvement of _______. |  | Definition 
 
        | Sacroiliitis 2+ Spondylitis 2+
 Peripheral arthritis 4+
 
 GU and eye
 |  | 
        |  | 
        
        | Term 
 
        | Inflammatory Bowel Syndrome is characterized by ______ and involvement of _______. |  | Definition 
 
        | Sacroiliitis 1+ Spondylitis 2+
 Peripheral arthritis 3+
 
 GI and eye
 |  | 
        |  | 
        
        | Term 
 
        | Inflammatory Bowel Syndrome is caused by _______ and ________. |  | Definition 
 
        | Crohn’s disease & Ulcerative colitis (GI) |  | 
        |  | 
        
        | Term 
 
        | Psoriatic Arthritis involves ______ |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Spondylitis is treated with _____. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Sacroiliitis is treated with ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Sjogren's Syndrome is a chronic ______, inflammatory disorder of ________ dysfunction. |  | Definition 
 
        | Chronic immune-mediated, inflammatory disorder of exocrine gland dysfunction |  | 
        |  | 
        
        | Term 
 
        | Sjogren's Syndrome is characterized by, dry ____ and _____. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Sjogren's Syndrome has the presence of autoantibodies: ___________. |  | Definition 
 
        | (ANA, rheumatoid factor, anti-Ro (SS-A) or anti-La (SS-B) |  | 
        |  | 
        
        | Term 
 
        | Sjogren's Syndrome is diagnosed by the presence of _____ and biopsy of the ______, which demonstrates characteristics of _______. |  | Definition 
 
        | Autoantibodies 
 Upper lip salivary gland
 
 lymphocytic inflitrate
 |  | 
        |  | 
        
        | Term 
 
        | Sjogren's Syndrome is treated with: _______. |  | Definition 
 
        | Artificial Tears Artificial Saliva
 Vaginal Lubricant
 |  | 
        |  | 
        
        | Term 
 
        | Systemic lupus erythematosus involves _____ on certain target organs. |  | Definition 
 
        | Immune complex deposition |  | 
        |  | 
        
        | Term 
 
        | Systemic lupus erythematosus partially results from impaired clearance of _______ and ______. |  | Definition 
 
        | apoptotic cells and immune complexes |  | 
        |  | 
        
        | Term 
 
        | 90% of the patients with SLE are ____. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | SLE has 25% concordance in ________ twins. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Null alleles with deficiency of ____, ____, or ______ — are a strong risk factor for lupus |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | In 70% of patients with SLE there are ______ autoantibodies present. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Other autoantibodies associated with SLE are: __________. |  | Definition 
 
        | Anti Ro (ribonucleoprotein complex) •Anti La (RNA binding protein)
 •Anti C1q (subunit of C1 complement)
 •Anti Sm (nuclear particles
 |  | 
        |  | 
        
        | Term 
 
        | The detection of different autoantibody types in SLE is associated with ______. |  | Definition 
 
        | Different clinical manifestations |  | 
        |  | 
        
        | Term 
 
        | The two most common autoantibodies associated with SLE are _____ and ____ and their main clinical effects are ________ & _______ disease. |  | Definition 
 
        | Anti-double stranded DNA Nucleosomes
 
 Kidney and Skin disease
 |  | 
        |  | 
        
        | Term 
 
        | SLE Pathogenic autoantibodies in Lupus have properties that enable them to ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Autoantibody development in SLE is _______ driven |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | In order for the antigen to drive lupus it has to be recognized as _____ and presented by an APC to _____ or from a T cell to a ____. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | _______ can be provided by apoptotic cells. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | SLE Clinical manifestations: ____________. |  | Definition 
 
        | Rashes, arthritis, glomerulonephritis or nephrotic syndrome, neuropsychiatric lupus, hemolytic anemia |  | 
        |  | 
        
        | Term 
 
        | SLE can present with a ____ rash. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | In addition to the butterfly rash, Lupus can present on the skin as ______. |  | Definition 
 
        | Discoid Lupus, localized raised areas of skin |  | 
        |  | 
        
        | Term 
 
        | Drug Induced Lupus is associated with an _____ antigen in 95% of cases and 70% for SLE. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | ______ antigen is associated with 40% of SLE cases and none in Drug Induced Lupus. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Mixed connective tissue disease have overlap between _______, _______, and ______. |  | Definition 
 
        | SLE, scleroderma, and myositis |  | 
        |  | 
        
        | Term 
 
        | 40% of Mixed connective tissue disease has _______ involvement. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Mixed connective tissue disease is associated with the specific Ab, _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Antiphospholipid syndrome, Clinical manifestations: ___________. |  | Definition 
 
        | –Arterial thrombosis (including stroke, MI) –Venous thrombosis
 –Recurrent fetal loss
 –Thrombocytopenia
 –Catastrophic antiphospholipid syndrome
 |  | 
        |  | 
        
        | Term 
 
        | Classic Antiphospholipid syndrome presentation is with _______. |  | Definition 
 
        | Livedo reticularis, a pale net like rash on the extremeties |  | 
        |  | 
        
        | Term 
 
        | Antiphospholipid syndrome is diagnosed by detection of the _________ and _______ in the labs. |  | Definition 
 
        | Lupus anticoagulant (clots in body though) Antiphopholipid antibodies
 |  | 
        |  | 
        
        | Term 
 
        | Key history for individuals with Antiphospholipid syndrome, include ______ & _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Antiphospholipid syndrome is treated with ______ and _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Vasculitis is inflammation of the ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Vasculitis Autoimmune markers include: _________ and ______. |  | Definition 
 
        | Anti-proteinase 3 antibodies 
 Anti-myeloperoxidase antibodies
 |  | 
        |  | 
        
        | Term 
 
        | Vasculitis of the large sized arteries includes: __________. |  | Definition 
 
        | Takayasu arteritis 
 Giant cell arteritis
 
 Behcet’s disease
 |  | 
        |  | 
        
        | Term 
 
        | Takayasu arteritis occurs in _____ and is characterized by: _________. |  | Definition 
 
        | Young women 
 fever, weight loss, arthritis
 |  | 
        |  | 
        
        | Term 
 
        | Giant cell arteritis occurs in _______ and presents with _____. |  | Definition 
 
        | >50 
 Large bulging temporal artery
 |  | 
        |  | 
        
        | Term 
 
        | Behcet’s disease is characterized by _________ and _______. |  | Definition 
 
        | Mucocutaneous ulcers (oral, genital, ileum, cecal) 
 Ocular inflammation
 |  | 
        |  | 
        
        | Term 
 
        | Behcet’s disease is diagnosed by _______. |  | Definition 
 
        | Pathergy, needle stick and look for circle reaction around injection site |  | 
        |  | 
        
        | Term 
 
        | Vasculitis of Medium sized arteries includes: ___________. |  | Definition 
 
        | Polyarteritis nodosa 
 Buerger’s disease
 
 Kawasaki
 |  | 
        |  | 
        
        | Term 
 
        | Polyarteritis nodosa is developed in people who have active ______ and ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Polyarteritis nodosa are specific to the affected organ but often include: _________. |  | Definition 
 
        | skin, heart (MI, heart failure, pericarditis), kidneys (renal failure), and nervous system |  | 
        |  | 
        
        | Term 
 
        | With Buerger’s Disease aka Thromboangiitis obliterans, blood vessels __________. |  | Definition 
 
        | blood vessels of the hands and feet become blocked |  | 
        |  | 
        
        | Term 
 
        | With Buerger’s Disease aka Thromboangiitis obliterans occurs most in ________. |  | Definition 
 
        | Tobacco users (heavy smokers) |  | 
        |  | 
        
        | Term 
 
        | Kawasaki is the leading cause of _____ in children. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Kawasaki affects the _____ arteries and can lead to aneurysms. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Kawasaki presents with ______, ______, and _______. |  | Definition 
 
        | Strawberry tongue 
 skin rashes on the middle of the body
 
 edema of hands and feet
 |  | 
        |  | 
        
        | Term 
 
        | Vasculitis of the small sized arteries can be _______ mediated or _____ associated. |  | Definition 
 
        | Immune complex mediated 
 ANCA associated
 |  | 
        |  | 
        
        | Term 
 
        | Vasculitis of the small sized arteries Immune complex mediated: _______. |  | Definition 
 
        | •Leukocytoclastic (cutaneous) vasculitis (Arthus reaction)
 •Henoch-Schoenlein: children>adults
 • Cryoglobulinemia;
 |  | 
        |  | 
        
        | Term 
 
        | Vasculitis of the small sized arteries ANCA associated: __________. |  | Definition 
 
        | •Wegener’s granulomatosus (cANCA) •Churg Strauss syndrome: middle age onset asthma vasculitis
 •Microscopic polyangiitis (cANCA, MPOab
 and proteinase 3)
 |  | 
        |  | 
        
        | Term 
 
        | ANCA associated Vasculitis of the small sized arteries in Wegener's is due to the autoantibody ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | SYSTEMIC SCLEROSIS (________) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Systemic Sclerosis is characterized by: ________, _____, _______. |  | Definition 
 
        | Cutaneous and visceral fibrosis 
 Vascular Dysfunction
 
 Immune activation
 |  | 
        |  | 
        
        | Term 
 
        | The Vascular Dysfunction associated with Systemic Sclerosis is responsible for the _________ phenomenon. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Classic Antiphospholipid syndrome presentation is with _______. |  | Definition 
 
        | Livedo reticularis, a pale net like rash on the extremeties |  | 
        |  | 
        
        | Term 
 
        | Antiphospholipid syndrome is diagnosed by detection of the _________ and _______ in the labs. |  | Definition 
 
        | Lupus anticoagulant (clots in body though) Antiphopholipid antibodies
 |  | 
        |  | 
        
        | Term 
 
        | Key history for individuals with Antiphospholipid syndrome, include ______ & _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Antiphospholipid syndrome is treated with ______ and _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Vasculitis is inflammation of the ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Vasculitis Autoimmune markers include: _________ and ______. |  | Definition 
 
        | Anti-proteinase 3 antibodies 
 Anti-myeloperoxidase antibodies
 |  | 
        |  | 
        
        | Term 
 
        | Vasculitis of the large sized arteries includes: __________. |  | Definition 
 
        | Takayasu arteritis 
 Giant cell arteritis
 
 Behcet’s disease
 |  | 
        |  | 
        
        | Term 
 
        | Takayasu arteritis occurs in _____ and is characterized by: _________. |  | Definition 
 
        | Young women 
 fever, weight loss, arthritis
 |  | 
        |  | 
        
        | Term 
 
        | Giant cell arteritis occurs in _______ and presents with _____. |  | Definition 
 
        | >50 
 Large bulging temporal artery
 |  | 
        |  | 
        
        | Term 
 
        | Behcet’s disease is characterized by _________ and _______. |  | Definition 
 
        | Mucocutaneous ulcers (oral, genital, ileum, cecal) 
 Ocular inflammation
 |  | 
        |  | 
        
        | Term 
 
        | Behcet’s disease is diagnosed by _______. |  | Definition 
 
        | Pathergy, needle stick and look for circle reaction around injection site |  | 
        |  | 
        
        | Term 
 
        | In SYSTEMIC SCLEROSIS, Scleroderma results in ______ skin. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | SYSTEMIC SCLEROSIS's visceral organ involvement can result in intestinal _______, leading to ______, ______, and ______. |  | Definition 
 
        | Intestinal hypomotility Bacterial overgrowth
 Diarrhea/malabsorption
 Constipation/bloating
 |  | 
        |  | 
        
        | Term 
 
        | SYSTEMIC SCLEROSIS's visceral organ involvement can result in Esophageal _____motility causing ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | SYSTEMIC SCLEROSIS results from a _______ defect in ________, that leads to the ________. |  | Definition 
 
        | Metabolic defect in fibroblast metabolism leading to the overproduction of collagen and other matrix proteins |  | 
        |  | 
        
        | Term 
 
        | SYSTEMIC SCLEROSIS damage is caused by ________ activation and _______. |  | Definition 
 
        | Immune cell activation and autoimmunity |  | 
        |  | 
        
        | Term 
 
        | In SYSTEMIC SCLEROSIS, Connective tissue matrix replaces: _________. |  | Definition 
 
        | subcutaneous fat, hair follicles, sweat and sebaceous glands |  | 
        |  | 
        
        | Term 
 
        | In SYSTEMIC SCLEROSIS, the dermis contains infiltrates of: _______. |  | Definition 
 
        | mononuclear cells, T lymphocytes and monocytes |  | 
        |  | 
        
        | Term 
 
        | Although there is endothelial damage, there is no ________ with systemic sclerosis as there is in Lupus and Wegners. |  | Definition 
 
        | No vasculitits (inflammation) |  | 
        |  | 
        
        | Term 
 
        | Two types of Systemic Sclerosis: _______. |  | Definition 
 
        | Limited cutaneous (lcSSc) 
 Diffuse cutaneous (dcSSc)
 |  | 
        |  | 
        
        | Term 
 
        | Limited cutaneous (lcSSc) is characterized by skin thickening that is ________. |  | Definition 
 
        | limited to the distal extremities (Fingers, toes and face) |  | 
        |  | 
        
        | Term 
 
        | Limited cutaneous (lcSSc) results in loss of joint mobility with _______. Their is also a loss of ______ and _____, which leaves the skin dry and prone to ________. |  | Definition 
 
        | Contractures 
 Loss of hair and sweat glands which leads to dry skin that is prone to fissures and infections
 |  | 
        |  | 
        
        | Term 
 
        | In Limited cutaneous (lcSSc), ______ involvment is more uncommon. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Diffuse Cutaneous (dcSSc) is characterized by Rapid and progressive symmetrical induration of the skin of the __________. |  | Definition 
 
        | extremities, face and trunk |  | 
        |  | 
        
        | Term 
 
        | In Diffuse Cutaneous (dcSSc), visceral organ involvement is common with ______ disease, _______ lung disease, and _______ involvement. |  | Definition 
 
        | Visceral organ involvement common with renovascular disease, interstitial inflammatory lung disease and cardiac involvement the most serious. |  | 
        |  | 
        
        | Term 
 
        | With SYSTEMIC SCLEROSIS, Raynaud’s phenomenon is a _______ response consisting of: _________. |  | Definition 
 
        | Triphasic vascular response Pallor
 Cyanosis
 Reactive hyperemia
 |  | 
        |  | 
        
        | Term 
 
        | Raynaud’s phenomenon May be seen in _____% of pts with SSc and may precede other manifestations by years |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | In addition to SSc, Raynaud’s phenomenon is seen in other connective diseases: __________. |  | Definition 
 
        | SLE Dermatomyositis
 Rheumatoid arthritis
 |  | 
        |  | 
        
        | Term 
 
        | The vascular features of SSc, include _____ of the face, hands, chest, and intestines (which may cause _____) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The vascular features of SSc, include dilated _______ capillaries and ______ ischemia. |  | Definition 
 
        | Dilated nail fold capillaries Digital ischemia, infection and infarction
 |  | 
        |  | 
        
        | Term 
 
        | SSc is a clinical diagnosis and is suggested by: _____________________. |  | Definition 
 
        | Raynaud’s phenomenon Esophageal reflux – heartburn
 Telangiectasias
 Sclerodactyly
 Antinuclear antibodies
 |  | 
        |  | 
        
        | Term 
 
        | For SSc, which type is suggested by the detection of Antinuclear Ab that are Nucleolar Pattern? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | For SSc, which type is suggested by the detection of Antinuclear Ab that are Anticentromeres? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | For SSc, 30-50% of dcSSc patients have ______ antibody, which is an auto antibody against _________ and leaves patients with a higher risk for ______ and ____ disease. |  | Definition 
 
        | Scl-70 
 topoisomerase
 
 renal and lung disease
 |  | 
        |  | 
        
        | Term 
 
        | For lcSSc patients, 50% have the ______ antibody, which leaves them at higher risk for _______. |  | Definition 
 
        | Anticentromere antibodies 
 Pulmonary Hypertension
 |  | 
        |  | 
        
        | Term 
 
        | SSc presentation, CREST Syndrome: |  | Definition 
 
        | Calcinosis Raynaud phenomenon
 Esopageal dysmotility
 Sclerodactyly
 Telangiectasias
 |  | 
        |  | 
        
        | Term 
 
        | THE IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS): ____________ |  | Definition 
 
        | Polymyositis Dermatomyositis
 Myositis associated with malignancy
 Myositis associated with connective tissue disease
 Inclusion body myositis
 |  | 
        |  | 
        
        | Term 
 
        | The older you get, the higher chance you have of getting _____ and ______ type of THE IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) |  | Definition 
 
        | Malilgnancy and inclusion body |  | 
        |  | 
        
        | Term 
 
        | THE IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) are mostly ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | With THE IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS), ______ is inflammation of the endomysial. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | With THE IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS), ______ is inflammation of the perimysial and blood vessels
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Anti-Jo 1 (also known as antisynthetase) is associated with which IIMS? |  | Definition 
 
        | Polymyositis or dermatomyositis |  | 
        |  | 
        
        | Term 
 
        | Anti-Jo 1 (also known as antisynthetase) is associated with the IIMS's Polymoysitis and dermatomyositis. It's clinical features are _______ and ______. |  | Definition 
 
        | Acute interstitial lung disease Arthritis
 Raynaud’s phenomenon
 |  | 
        |  | 
        
        | Term 
 
        | Anti-SRP is associated with which IIMS? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Anti-SRP is associated with the IIMS Polymoysitis. Its clinical features include an _____ onset with severe _______ and ______. |  | Definition 
 
        | Abrupt 
 Severe weakness
 Palpitations
 |  | 
        |  | 
        
        | Term 
 
        | Anti-Mi2 is associated with which IIMS's? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Anti-Mi2 is associated with the IIMS, Dermatomyositis, and its clincial features are the ______ sign and _________ |  | Definition 
 
        | V sign (shawl sign) Cuticular overgrowth
 |  | 
        |  | 
        
        | Term 
 
        | THE IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) are a ______ type of disorder with ______ present. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | THE IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) are associated with: ________  especially, ________. |  | Definition 
 
        | Hashimoto’s thyroiditis, myasthenia gravis, primary biliary cirrhosis 
 connective tissue diseases
 |  | 
        |  | 
        
        | Term 
 
        | With THE IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) there are _______ in a biopsy. |  | Definition 
 
        | T cells cytoxic to muscle |  | 
        |  | 
        
        | Term 
 
        | In addition to the cytoxic T cells against muscle tissue, there is immunoglobulin ______ in dermatomyositis |  | Definition 
 
        | deposition and complement components in the capillaries and small arterioles (dermatomyositis) |  | 
        |  | 
        
        | Term 
 
        | THE IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) can occur insidious, over months and present with ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | THE IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) can occur Indolent, over years with __________ weakness |  | Definition 
 
        | proximal and distal muscle  weakness |  | 
        |  | 
        
        | Term 
 
        | THE IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS), 50% present with ______, others with _______ indicating cardiac/lung involvement, and others with __________ (_________). |  | Definition 
 
        | Myalgia, 
 Dyspnea
 
 Dermatomyositis (skin eruption prior to myositis)
 |  | 
        |  | 
        
        | Term 
 
        | Dermatomyositis (skin eruption prior to myositis) is characterized by a _____ rash that has several different varietis: _______lesions Erythematous rash
 Poikilodermatous rash
 Heliotrope rash
 |  | Definition 
 
        | Rthe rash 
 Gottron lesions/papules
 |  | 
        |  | 
        
        | Term 
 
        | Gottron papules consist of _______, sometimes ____ papules, plaques, or macules. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Gottron sign for THE IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) is _________. |  | Definition 
 
        | Lesions over metacarpophalangeal and proximal interphalangeal joints |  | 
        |  | 
        
        | Term 
 
        | THE IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) for dermatomyotis presents with a _______ on the anterior ________ or the _______ sign on the _______. |  | Definition 
 
        | V shape on anterior chest 
 Shawl sign on the back
 |  | 
        |  | 
        
        | Term 
 
        | EXTRAMUSCULAR MANIFESTATIONS of IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) are primarily of _______ involvement. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The Extramuscular manifestations of IIMS with Interstitial Lung Disease, 10-30% have the auto antibody _____. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cardiac extramuscular manifestations in Polymyositis and Dermatomyositis include: __________. |  | Definition 
 
        | • Heart block • Arrhythmias
 • Cardiomyopathy
 |  | 
        |  | 
        
        | Term 
 
        | Gastrointestinal extramuscular manifestations in Polymyositis and Dermatomyositis include __________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Pulmonary extramuscular manifestations in Polymyositis and Dermatomyositis include __________. |  | Definition 
 
        | Interstitial lung disease |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Polymyositis is a rare inflammatory disease that leads to muscle weakness, swelling tenderness, and tissue damage. It is part of a larger group of diseases called myositis. |  | 
        |  | 
        
        | Term 
 
        | THE IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS) are diagnosed by a ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | THE IDIOPATHIC INFLAMMATORY MYOPATHIES (IIMS), Therapy: _______. |  | Definition 
 
        | (Unlike SSc, there is therapy) Steroids
 Azathiopine
 Methotrexate
 Cyclosporine
 Cyclophospamide
 Mycophenolate
 IVIG for dermatomyositis
 |  | 
        |  | 
        
        | Term 
 
        | With the IDIOPATHIC INFLAMMATORY MYOPATHIES there is a 2-fold increase in _____ risk. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cardinal feature of OA is the _____ of articular cartilage and the ________. |  | Definition 
 
        | progressive loss 
 remodeling of subchondral bone
 |  | 
        |  | 
        
        | Term 
 
        | Joint failure results from a variety of pathways subsequent to _____ or repetitive injury |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Steps in OA pathogenic development: ________. |  | Definition 
 
        | 1, stress 2, inflammatory response
 3, cartilage breakdown products enhance inflammatory response
 4, perpetuation of cartilage damage
 5, complete loss of cartilage, erosion of subchondral bone, formation of osteophytes
 |  | 
        |  | 
        
        | Term 
 
        | Clinical Features of OA: _______, ______ and ______ examination. |  | Definition 
 
        | Pain Stiffness of Short Duration (less than 30 mins, RA is >1 hr)
 Joint examination
 |  | 
        |  | 
        
        | Term 
 
        | Joint examination of OA will reveal _______ with movement, a limitation of _______, and joint _______. |  | Definition 
 
        | –Crepitus with movement –Limitation of motion
 –Joint deformity and/or laxity
 |  | 
        |  | 
        
        | Term 
 
        | OA has maximal or minimal swelling? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | In order to differentiate OA from RA, joints that are not typically involved in OA include: ____________ (unless trauma/conginetal) |  | Definition 
 
        | shoulder, elbow, wrist and ankle |  | 
        |  | 
        
        | Term 
 
        | Joints commonly affected by OA: _______. |  | Definition 
 
        | Cervical Spine Lumbar Spine
 Hips
 Distal Interphalangeal
 Knees
 Metatarsals
 |  | 
        |  | 
        
        | Term 
 
        | Palpation of the joints: RA ______
 OA _______
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Presence of ________ suggests other etiology other than RA. |  | Definition 
 
        | extra-articular manifestations |  | 
        |  | 
        
        | Term 
 
        | Extra-articular manifestation, Fever, is more likely: ________ than OA. |  | Definition 
 
        | gout, infectious arthritis |  | 
        |  | 
        
        | Term 
 
        | Extra-articular manifestation, Rash, is more likely: ________ than OA. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Extra-articular manifestation, Nodules, is more likely: ________ than OA. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Extra-articular manifestation, Neuropathy, is more likely: ________ than OA. |  | Definition 
 
        | polyarteritis nodusa, Wegener granulamatosis |  | 
        |  | 
        
        | Term 
 
        | Typical hand deformities in osteoarthritis: –__________ on DIPs
 –__________ on PIPs
 |  | Definition 
 
        | Heberden's nodes 
 Bouchard's nodes
 |  | 
        |  | 
        
        | Term 
 
        | Radiographic Diagnosis of OA: ______. |  | Definition 
 
        | Osteophytes (arrows) and medial joint space narrowing more on one side |  | 
        |  | 
        
        | Term 
 
        | Radiographic Diagnosis of RA: _______. |  | Definition 
 
        | Almost complete symmetrical loss of joint space in both the medial and the lateral compartment, but with little subchondral sclerosis or osteophyte formation |  | 
        |  | 
        
        | Term 
 
        | Three types of OA: _______. |  | Definition 
 
        | Erosive inflammatory OA Nodal OA
 Routine OA
 |  | 
        |  | 
        
        | Term 
 
        | Erosive inflammatory OA, flares of _____ occur and is destructive of the ______. |  | Definition 
 
        | inflammation 
 finger joints
 |  | 
        |  | 
        
        | Term 
 
        | Erosive inflammatory OA can be differentiated from RA by _______. |  | Definition 
 
        | lack of rheumatoid factor and asymmetrical |  | 
        |  | 
        
        | Term 
 
        | Nodal OA occurs mainly in _____ and has a correlation with _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | In Nodal OA, the ______ joints are mainly involved. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Routine OA is due to ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | In the treatment of Mild – moderate OA, ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | In the treatment of Moderate to severe OA, ________ (In order of increasing severity). |  | Definition 
 
        | –NSAIDS at lowest effective dose –High-dose NSAIDS plus proton pump inhibitor of misoprostol for gastric protection
 –Intra-articular corticosteriods
 –Opiates or synthetic opioids (e.g, tramadol)
 |  | 
        |  | 
        
        | Term 
 
        | Proton pump inhibitor drug, _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Pharmacologic Treatment of OA can be supplemented with ________ or _______. |  | Definition 
 
        | Topical NSAIDS or capsaicin |  | 
        |  | 
        
        | Term 
 
        | Crystals Observed in Joints: _______. |  | Definition 
 
        | Monosodium urates Calcium pyrophosphate dihydrate
 |  | 
        |  | 
        
        | Term 
 
        | Monosodium urates crystals are associated with ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Calcium pyrophosphate dihydrate are associated with ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Monosodium urates crystals are ______ in Tissue and _______ in fluid. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Calcium pyrophosphate dihydrate crystals are ______ in Tissue and _______ in fluid. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Main classes of people at risk for Gout: ________. |  | Definition 
 
        | Men >35 years of age, post-menopausal women, organ transplant recipients |  | 
        |  | 
        
        | Term 
 
        | Why are post menopausal women more susceptible to gout? |  | Definition 
 
        | Estrogen enhances rate of uric acid excretion |  | 
        |  | 
        
        | Term 
 
        | Serum uric acid levels must be at least ______ to develop gout. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 10% of the cases of Gout are the result of _____ or _____ of uric acid. |  | Definition 
 
        | Overproduction or overconsumption |  | 
        |  | 
        
        | Term 
 
        | Primary causes of gout account for _____ cases and are _______. |  | Definition 
 
        | <2% 
 Genetic deficiencies in enzymes
 |  | 
        |  | 
        
        | Term 
 
        | Secondary causes of Gout include: ________. |  | Definition 
 
        | •Myeloproliferative and lymphoproliferative diseases (producing lots of cells and therefore need lots of purines) •Chemotherapy of malignancies (purines from dead cells)
 •Ethanol consumption
 |  | 
        |  | 
        
        | Term 
 
        | _____ of uric acid accounts for 90% of the cases of Gout. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Acute gout is characterized by ______ onset of _________, accompanied by _____ and _____. |  | Definition 
 
        | Rapid onset of intense pain 
 Erythema, swelling
 |  | 
        |  | 
        
        | Term 
 
        | Most frequent site for first attack of acute gout is ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Polyarticular gout aka (________) involves _______. |  | Definition 
 
        | (gouty arthritis) 
 multiple joints
 |  | 
        |  | 
        
        | Term 
 
        | Chronic tophaceous gout is characterized by ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Gout is associated with increased levels of urate in the urine, leading to _______. |  | Definition 
 
        | kidney stones (calcium oxalate stones – nephrolithiasis) |  | 
        |  | 
        
        | Term 
 
        | Gout is associated with high levels of Monosodium urate (MSU) which can cause ______ around the joints. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Monosodium urate (MSU) deposition is associated with Gout and can cause _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Podagra / gouty arthritis is characterized by swelling of the ______, and a dusky blue hue over an _________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Tophaceous gout, nodules are _______ and full of _______  and there is no surrounding ________. |  | Definition 
 
        | painless 
 uric acid crystals
 
 swelling or erythema
 |  | 
        |  | 
        
        | Term 
 
        | Chronic gout is characterized by chronic ________ with tenderness and swelling. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | In chronic gout _______ are present. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Gout can be differentiated from Septic arthritis by checking for ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Gout can be differentiated from Cellulitis by checking for ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Acute gout, in 95% of the patients there was ______ |  | Definition 
 
        | Serum uric acid >7.5 mg/dL |  | 
        |  | 
        
        | Term 
 
        | Monosodium urate crystals are _____ in fluid and _____ refractile |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Monosodium urate crystals are ______ under polarized light microscopy. |  | Definition 
 
        | Negatively birefringent Blue/Red
 |  | 
        |  | 
        
        | Term 
 
        | For Acute Gouty attacks, treat initially with the ________, _________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | For Acute Gouty attacks, treat with any NSAIDS, especially Indomethacin, but not ______ or _____. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | In addition to the primary treatment of NSAIDS (Indomethacin) for Acute Gout, _______ can be administered. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | In order to decrease urate formation, a ________ inhibitor, _________ can be administered for moderate to severe gout to prevent the conversion of ______ to ______. |  | Definition 
 
        | ALLOPURINOL 
 Xanthine oxidase inhibitor
 
 inhibit conversion of hypoxanthine to xanthine to uric acid
 |  | 
        |  | 
        
        | Term 
 
        | In order to increase urate excretion, a ______ type of drug called _______ can be administered, which inhibits ________. |  | Definition 
 
        | Uricosuric 
 Probenecid
 
 Inhibits tubular reabsorption of urate
 |  | 
        |  | 
        
        | Term 
 
        | NSAIDs first-line treatment for acute gout – _____ or ______. |  | Definition 
 
        | indomethacin or COX-2 inhibitor |  | 
        |  | 
        
        | Term 
 
        | First line for lowering Urate for Chronic Tophi Gout is: a xanthine oxidase inhibitor such as ______ or a uricosuric agent such as ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Do NOT give allopurinol during _______ – any change in uric acid level worsens attacks |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | ______ can be used for prophylaxis treatment of Chronic Tophi Gout. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | If there is failure to lower uric acid levels with single therapy, use one _______ and one _______. If still unsuccessful add ________. |  | Definition 
 
        | 1 xanthine inhibitor (allopurinol) and 1 uricosuric agent (probenicid) 
 pegloticase
 |  | 
        |  | 
        
        | Term 
 
        | Patients with hyperuricemia caused by tumor lysis syndrome are treated with ______ or ______. |  | Definition 
 
        | Rasburicase (allergenic) or pegloticase (uricosuric agents) |  | 
        |  | 
        
        | Term 
 
        | Corticosteroids are used to treat which type of gout? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Calcium Pyrophosphate Dihydrate Deposition Disease (CPDD) affects _____ and ______. |  | Definition 
 
        | cartilage and fibrocartilage |  | 
        |  | 
        
        | Term 
 
        | Calcium Pyrophosphate Dihydrate Deposition Disease (CPDD) presents as ______. |  | Definition 
 
        | Acute arthritis (Often seen in post-op patient) |  | 
        |  | 
        
        | Term 
 
        | Calcium Pyrophosphate Dihydrate Deposition Disease (CPDD) is diagnosed by the presenced of ______ crystals in the fluid, which are _____ refractive. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Calcium Pyrophosphate Dihydrate Deposition Disease (CPDD), Calcium pyrophosphate crystals are ________ bifringment. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | CPDD, Acute pseudogout is treated with _______ and ______. |  | Definition 
 
        | Systemic corticosteroids or NSAIDs |  | 
        |  | 
        
        | Term 
 
        | CPDD, Pseudo RA is treated with _______ and ______. |  | Definition 
 
        | corticosteroids and methotrexate |  | 
        |  | 
        
        | Term 
 
        | Uric acid is produced from the breakdown of _______. |  | Definition 
 
        | purines (adenine, guanine) |  | 
        |  | 
        
        | Term 
 
        | 2/3 of the uric acid in the body comes from ______ and 1/3 from ______. |  | Definition 
 
        | 2/3 comes from de novo synthesis and/or salvage pathways 
 1/3 diet
 |  | 
        |  | 
        
        | Term 
 
        | Uric acid, 2/3 excreted via _____; 1/3 through _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Sarcoidosis is a chronic disease of _________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Sarcoidosis is a multisystem _______ disease of _______ etiology. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Sarcoidosis is a disease of disordered immune ______ in _______ persons exposed to ________. |  | Definition 
 
        | Disease of disordered immune regulation in genetically predisposed persons exposed to certain environmental agents |  | 
        |  | 
        
        | Term 
 
        | For Sarcoidosis, the diagnostic histopathic feature is _____________. |  | Definition 
 
        | noncaseating granulomas in various tissues |  | 
        |  | 
        
        | Term 
 
        | Sarcoidosis, high levels of ______ cells in the lungs or sites of ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | In Sarcoidosis there is massive local secretion of ____-dependent cytokines-_____. |  | Definition 
 
        | Local secretion of Th1-dependent cytokines – IFN-g (by CD4+ T cells ) |  | 
        |  | 
        
        | Term 
 
        | Primary organ affected in Sarcoidosis? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Sarcoidosis 75-95% exhibit _______ whiles 75% exhibit ________. |  | Definition 
 
        | lymphadenopathy 
 spleen granulomas
 |  | 
        |  | 
        
        | Term 
 
        | Sarcoidosis primarily affects _____ lymph nodes. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Sarcoidosis can affect glands, particularly the ______ resulting in _____ from the production of active _____ by activated macrophages. |  | Definition 
 
        | parathyroid gland 
 hypercalcaemia
 
 Vitamin D
 |  | 
        |  | 
        
        | Term 
 
        | Sarcoidosis manifests in the skins as ________. |  | Definition 
 
        | erythema nodosum (skin nodules, so does gout) |  | 
        |  | 
        
        | Term 
 
        | Sarcoidosis, multisystem disease, affects: ________ |  | Definition 
 
        | Lungs Heart
 Skeletal Muscle
 Liver
 Lymph Nodes
 Spleen
 Glands
 Skin
 Eyes
 Bone Marrow
 |  | 
        |  | 
        
        | Term 
 
        | Sarcoidosis surprisingly does not have a higher incidence among ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Sarcoidosis Appears to be due to development of ______ response against an unidentified antigen |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Sarcoidosis, there is initially an Intra-alveolar and interstitial accumulation of ______ cells. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | In Sarcoidosis, the T cell subsets are of ______ origin. |  | Definition 
 
        | from one common, Oligoclonal expansion |  | 
        |  | 
        
        | Term 
 
        | In Sarcoidosis, the CD4+ TH1 cells release TH1 cytokines _______ causing _______, and ______ causing _______. |  | Definition 
 
        | IL-2 (T cell expansion) and IFN-γ (macrophage activation) |  | 
        |  | 
        
        | Term 
 
        | In Sarcoidosis, following macrophage activation, additional cytokines are released resulting in ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | One of the common side effects of Sarcoidosis is the anergy to ______, due to the ________. |  | Definition 
 
        | common skin test antigens 
 peripheral T cell depletion
 |  | 
        |  | 
        
        | Term 
 
        | After the T cells have gone haywire in Sarcoidosis, ______ results for the B cells. |  | Definition 
 
        | Polyclonal hypergammaglobulinemia |  | 
        |  | 
        
        | Term 
 
        | Sarcoidosis has genetic involvement and association with certain _____ genotypes. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 2/3 of Sardoisis cases present with ______ that appeared gradually |  | Definition 
 
        | respiratory symptoms (Shortness of breath, cough, vague chest pain) |  | 
        |  | 
        
        | Term 
 
        | In addition to resp sympts Sardoisis patients also present with ____, ____, _____, or ______. |  | Definition 
 
        | peripheral LAD, cutaneous lesions, splenomegaly, or hepatomegaly |  | 
        |  | 
        
        | Term 
 
        | Sarcoidosis remission may be spontaneous or initiated by ______ therapy. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 10-15% of Sarcoidosis pts die from _____. |  | Definition 
 
        | progressive pulmonary fibrosis |  | 
        |  | 
        
        | Term 
 
        | Sarcoidosis should be considered for any patients of the age of _________ with _______ complaints, _______ vision, _______ skin condition, or ________. |  | Definition 
 
        | 20-40 with respiratory complants, blurry vision, erythema nodosum and hilar lymphadenopathy |  | 
        |  | 
        
        | Term 
 
        | Sarcoidosis WBC will indicate _______ and _______. |  | Definition 
 
        | lymphocytopenia and eosinophila |  | 
        |  | 
        
        | Term 
 
        | Sarcoidosis will show a decreased/increased erythocyte sedimentation rate |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Sarcoidosis will show hypo/hyperglobulinemia |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Sarcoidosis labs will show elevated _____ levels. |  | Definition 
 
        | ACE (angiotensin-converting enzyme) |  | 
        |  | 
        
        | Term 
 
        | Definitive diagnosis of Sarcoidosis requires ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Sarcoidosis ex. presentation: _____________. |  | Definition 
 
        | A 26-year-old African American woman presented with fever, malaise, weight loss, and erythema nodosum She reported shortness of breath and dry cough.
 Radiograph showed hilar LAD and mediastinal LAD; nodules were also present in the lungs
 |  | 
        |  | 
        
        | Term 
 
        | Sarcoidosis tissue samples have _______ and an absolute indicator is the presence of ______. |  | Definition 
 
        | Noncaseous granulomas 
 Asteroid bodies
 |  | 
        |  | 
        
        | Term 
 
        | Sarcoidosis is treated with a high dose _______. |  | Definition 
 
        | glucocorticoid taper (prednisolone) |  | 
        |  | 
        
        | Term 
 
        | For the treatment of steroid resistant Sarcoidosis: ___________. |  | Definition 
 
        | (Autoimmune Drugs) Methotrexate
 Hydroxychloroquine (antimalarial)
 TNF-a inhibitors
 |  | 
        |  | 
        
        | Term 
 
        | Primary immunodeficiency ______ determined. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Secondary immunodeficiency states are the results of ______ and ______. |  | Definition 
 
        | Complications of cancers, infections 
 Side effects of immunosuppression/chemotherapy
 |  | 
        |  | 
        
        | Term 
 
        | X-linked agammaglobulinemia (Bruton’s) results from a mutation in _______, causing a ____ cell immunodeficiency. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | X-linked agammaglobulinemia (Bruton’s) mutation in BTK results in the failure of ________. |  | Definition 
 
        | Failure of B cell maturation |  | 
        |  | 
        
        | Term 
 
        | X-linked agammaglobulinemia (Bruton’s) overall affect is an _________.
 |  | Definition 
 
        | Absence of antibodies, circulating B cells, and plasma cells |  | 
        |  | 
        
        | Term 
 
        | X-linked agammaglobulinemia (Bruton’s), 20% develop ______. |  | Definition 
 
        | develop autoimmune diseases – RA, dermatomyositis |  | 
        |  | 
        
        | Term 
 
        | X-linked agammaglobulinemia (Bruton’s), infection onset by ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Selective (isolated) IgA deficiency is the most common ____ deficiency. It is a deficiency of ____ cells. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Selective (isolated) IgA deficiency results in a block in ______. |  | Definition 
 
        | differentiation of IgA-secreting cells |  | 
        |  | 
        
        | Term 
 
        | With Selective (isolated) IgA deficiency other than IgA, other Ig are _______. |  | Definition 
 
        | Other immunoglobulins normal or increased |  | 
        |  | 
        
        | Term 
 
        | Selective (isolated) IgA deficiency present clinically with ______. |  | Definition 
 
        | early childhood with recurrent sinopulmonary infections and diarrhea |  | 
        |  | 
        
        | Term 
 
        | Selective (isolated) IgA deficiency  has a significant association with ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Common variable immunodeficiency is characterized by _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | With Common variable immunodeficiency, _______ cells are present, but _______ cells are absent. |  | Definition 
 
        | B cells present, plasma cells absent |  | 
        |  | 
        
        | Term 
 
        | Common variable immunodeficiency is clinically similar to _______, with onset instead around ______. |  | Definition 
 
        | Bruton’s agammaglobulinemia 
 second decade of life
 |  | 
        |  | 
        
        | Term 
 
        | Common variable immunodeficiency is a _____ type of immunodeficiency. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Common variable immunodeficiency leaves pts prone to developing autoimmune diseases and ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Another type of B-Cell Deficiency is Transient hypogammaglobulinemia of infancy which occurs ________, when _______ is disappearing and baby B cells are not producing enough. |  | Definition 
 
        | 3-6 months of age when materal IgG is disappearing |  | 
        |  | 
        
        | Term 
 
        | DiGeorge syndrome aka (________). |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | DiGeorge syndrome (Thymic aplasia) results from the failure of the development of the _________. |  | Definition 
 
        | 3rd and 4th pharyngeal pouches |  | 
        |  | 
        
        | Term 
 
        | DiGeorge syndrome (Thymic aplasia)  results in _____, ______, and _____ defects (______ syndrome). |  | Definition 
 
        | Cardiac, vascular craniofacial defects 
 (velocardiofacial syndrome)
 |  | 
        |  | 
        
        | Term 
 
        | Complete absence of the thymus and T cells with DiGeorge syndrome (rare) is called _____. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Two types of Severe Combined Immunodeficiency Disease: _____. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Autosomal SCID are half due to mutations in _______, leading to toxic accumulation during ______ maturation and proliferation. |  | Definition 
 
        | adenosine deaminase (ADA) 
 lymphocyte
 |  | 
        |  | 
        
        | Term 
 
        | X-linked SCID is due to mutations in gene encoding _______ leading to loss of ______ receptors. |  | Definition 
 
        | common g chain 
 cytokine (for IL's)
 |  | 
        |  | 
        
        | Term 
 
        | With Severe Combined Immunodeficiency Disease May present with graft-versus-host disease from maternal T cells – ________  after birth |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Severe Combined Immunodeficiency Disease have _____ thymuses, lymph nodes, and mucosal lymphoid tissue. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Severe Combined Immunodeficiency Disease presents when? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Severe Combined Immunodeficiency Disease presents with? |  | Definition 
 
        | Diarrhea, otitis media, thrush, and respiratory infections |  | 
        |  | 
        
        | Term 
 
        | Hyper-IgM syndrome is an example of ______ Deficiency. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Hyper-IgM syndrome is a failure to produce _________. |  | Definition 
 
        | isotype-switched high-affinity antibodies (IgG, IgA, IgE) |  | 
        |  | 
        
        | Term 
 
        | Hyper-IgM syndrome exhibits normal to high levels of ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Hyper-IgM syndrome, 70% X-linked mutation in gene encoding _____ (T cell) and 30% autosomal, related to mutation in _____ (B cell) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | With Hyper-IgM syndrome and the failure of CD40-CD40L T-cell mediated activation of ______, pts are susceptible to _______. |  | Definition 
 
        | macrophages 
 intracellular pathogens and Pneumocystis jiroveci
 |  | 
        |  | 
        
        | Term 
 
        | Secondary (Acquired) Immune Deficiencies are Much more common than the primary (inherited) disorders, encountered in patients with: ___________. |  | Definition 
 
        | Malnutrition Infection
 Cancer
 Renal disease
 SarcoidosisMalnutrition
 Infection
 Cancer
 Renal disease
 Sarcoidosis**************
 |  | 
        |  | 
        
        | Term 
 
        | Most common cause of immune deficiency is _________. |  | Definition 
 
        | therapy-induced suppression of the bone marrow or of lymphocyte function |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Asprin is a ______ derivative. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 2 major class of NSAIDS and ex of each: _______. |  | Definition 
 
        | Salicyclic acid, Asprin Para-aminophenol, Acetaminophen
 |  | 
        |  | 
        
        | Term 
 
        | NSAIDS act by inhibiting the _______. |  | Definition 
 
        | cyclooxygenase (COX) enzyme |  | 
        |  | 
        
        | Term 
 
        | Inhibition of the COX enzyme by NSAIDS, blocks the production of _______ which mediate the pathogenesis of ______ and _____. |  | Definition 
 
        | prostaglandins 
 inflammation and fever
 |  | 
        |  | 
        
        | Term 
 
        | Inhibition of COX-_ is responsible for the therapeutic benefits. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | AA is cleaved from phospholipids by ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | AA is cleaved by _____ and _____. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | AA cleaved by Lipoxygenase generates ________. |  | Definition 
 
        | Leukotrines (bronchoconstirctors) |  | 
        |  | 
        
        | Term 
 
        | COX-1/2 cleavage of AA leads to the production of _____, _____, and _____. |  | Definition 
 
        | Thromboxanes Prostaglandins Prostacyclins |  | 
        |  | 
        
        | Term 
 
        | Loss of the therapuetic function of COX-1 leads to _____, _____, and _____ problems. |  | Definition 
 
        | Stomach (Bleeding/ulcers) 
 Hemostatis (loss of Thx, platelet aggregation)
 
 Kidney (PG/PC)
 |  | 
        |  | 
        
        | Term 
 
        | COX-1 is a _____ structure found where? |  | Definition 
 
        | Dimer 
 anchored to the membrane
 |  | 
        |  | 
        
        | Term 
 
        | What are the two key active site amino acids that bind AA in COX-1? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | In addition to the key amino acids, what motility also helps binding at the active site of AA by COX-1? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Asprin is a unique NSAIDS because it _______. |  | Definition 
 
        | Acetylates the serine residue on COX and therefore knocks it out permanetly |  | 
        |  | 
        
        | Term 
 
        | Asprin is used to knock out COX permanently and deprive ______ cells of ______. |  | Definition 
 
        | platelets 
 Thromboxane A-2
 |  | 
        |  | 
        
        | Term 
 
        | NSAIDS are what kinds of inhibitors? |  | Definition 
 
        | Competitive, bind at active site |  | 
        |  | 
        
        | Term 
 
        | COX-_ is expressed constitutively and in all tissues. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | COX2 is only expressed constitutively in: _______. |  | Definition 
 
        | Brain and parts of kidney |  | 
        |  | 
        
        | Term 
 
        | COX-2 is involved in the _____, while COX-1 is involved in ______. |  | Definition 
 
        | Inflammatory processes 
 Housekeeping
 |  | 
        |  | 
        
        | Term 
 
        | Side effects of NSAIDs because of the block of COX-1: _______ & _______. |  | Definition 
 
        | GI ulceration Blockade of platelet aggregation (Inhibition of Thbx synthesis)
 |  | 
        |  | 
        
        | Term 
 
        | Asprin is primarily a COX-_ inhibitor. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Naproxen (NSAID) is an inhibitor of _____. |  | Definition 
 
        | Almost COX-1 and 2 equally (little more COX-2) |  | 
        |  | 
        
        | Term 
 
        | Selective for COX-2, ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | How do COX-2 selective inhibitors work? |  | Definition 
 
        | Bind to side pocket in COX-2 that is not present in COX-1 |  | 
        |  | 
        
        | Term 
 
        | Celecoxib (Celebrex) was not withdrawn from the market, but other COX-2 selective inhibitors, ______ and ______, was. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | AA through the COX-2 pathway eventually produces a ____thrombotic Prostaglandin-I2. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The addition of Vioxx a COX-2 selective inhibitor, removes ______thrombotic. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | In platelets, AA through COX-1 (which Asprin targets) produces ______, which is a _____thrombotic factor. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The addition of Asprin through the blockage of COX-1 removes a ______thrombotic factor. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Vioxx puts you at risk for _____ because it removes an _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Acetylsalicylic acid (_____) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Traditional NSAID as a whole have functions: ______________. |  | Definition 
 
        | Anti-inflammatory Analgesia
 Antipyretic
 |  | 
        |  | 
        
        | Term 
 
        | Asprin is the only NSAID that is used for ______ function. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | All NSAIDs have an Anti-inflammatory function except for _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | NSAIDs achieve their Antipyretic by producing ____ which act on the Hypothalamus. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | NSAIDs achieve their Analgesia function by ______. |  | Definition 
 
        | Lowering pain transmission |  | 
        |  | 
        
        | Term 
 
        | All currently available NSAIDs inhibition _____ and _____ synthesis via inhibition of COX-1. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | NSAIDs are ______ protein bound. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | NSAIDs undergo ____ metabolism and many are excreted as _____ conjugates. |  | Definition 
 
        | hepatic 
 glucuronide conjugates
 |  | 
        |  | 
        
        | Term 
 
        | NSAIDs have ____ half lives. |  | Definition 
 
        | Varying, some short, some long |  | 
        |  | 
        
        | Term 
 
        | In order to prevent the GI toxicity associated with NSAIDs, a ______ analog, ________ is used to prevent ulceration and bleeding by acting as a _______. |  | Definition 
 
        | Prostagalandin E analog 
 misoprostol (Cytotec)
 
 H2 antagonist (proton pump inhibitor)
 |  | 
        |  | 
        
        | Term 
 
        | PGs are responsible for ______. |  | Definition 
 
        | Maintaining the integrity of the stomach |  | 
        |  | 
        
        | Term 
 
        | In addition to GI toxicity, NSAIDs are also associated with _____ toxicity. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Do hypersensitivities of NSAIDs exist? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Because of their high plasma protein binding and antiplatelet function, NSAIDs can _______ toxic effects. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | NSAIDs can cause CNS effects of, _________ at _______. |  | Definition 
 
        | Dizziness, anxiety, tinnitus, and confusion 
 Large Doses (>>2 grams)
 |  | 
        |  | 
        
        | Term 
 
        | ______ NSAID is associated with heaptic toxicity. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Acetaminophen is what class of NSAIDs? |  | Definition 
 
        | Para-aminophenol derivatives |  | 
        |  | 
        
        | Term 
 
        | Acetylsalicylic acid, (aspirin) serves as the prototype drug for the _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Acetylsalicylic acid, (aspirin) possesses functions of: _______ properties. |  | Definition 
 
        | analgesic, antipyretic, anti-inflammatory and antiplatelet |  | 
        |  | 
        
        | Term 
 
        | Aspirin (acetylsalicylic acid) is a weak organic ____ with a pKa of ___. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The breakdown of acetylsalicylic acid (Asprin) into _____ and _____ often leads to the ____-like odor of old aspirin tablets. |  | Definition 
 
        | acetic acid and salicylate 
 vinegar
 |  | 
        |  | 
        
        | Term 
 
        | Aspirin relieves _______ intensity pain such as headache, myalgia, arthralgia and other pains arising from integumental structures. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aspirin ______ ______ body temperature. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Salicylates Antipyretic effect? |  | Definition 
 
        | An effective reset the "thermostat" |  | 
        |  | 
        
        | Term 
 
        | Salicylates Antipyretic mechanism? |  | Definition 
 
        | heat loss is enhanced as a result of cutaneous vasodilation and sweating |  | 
        |  | 
        
        | Term 
 
        | Salicylates do/don't reduce exercise-induced hyperthermia. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The salicylates are used in the treatment of _____ diseases, bc of their Anti-inflammatory Effects. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | For salicylates, inhibition of ______ and _______ synthesis is the mechanism of anti-inflammatory action. |  | Definition 
 
        | prostaglandin 
 thromboxane
 |  | 
        |  | 
        
        | Term 
 
        | For salicylates, higher doses are required for effective _____ action, as compared to ________ doses. |  | Definition 
 
        | anti-inflammatory (Need higher to get COX-2) 
 analgesic and antipyretic
 |  | 
        |  | 
        
        | Term 
 
        | Aspirin does/doesn't inhibit the formation of leukotrienes via the lipoxygenase pathway. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The antiplatelet effect of aspirin comes _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aspirin's Antiplatelet Effect significantly reduces the incidence of ______ and ______ in patients at risk |  | Definition 
 
        | stroke and myocardial infarction |  | 
        |  | 
        
        | Term 
 
        | At the lowest therapuetic doses, aspirin produces prolongation of _______, due to decreased ________. |  | Definition 
 
        | bleeding time 
 platelet aggregation
 |  | 
        |  | 
        
        | Term 
 
        | Aspirin covalently ______ a serine at the active site of platelet cyclooxygenase, thereby reducing the formation of _______ which promotes platelet aggregation. |  | Definition 
 
        | acetylates 
 thromboxane A2
 |  | 
        |  | 
        
        | Term 
 
        | Salicylates _______ respiration directly and indirectly. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The direct stimulation by Salicylates  on respiration is due primarily to an action on ______ which control rate. |  | Definition 
 
        | medullary respiratory neurons |  | 
        |  | 
        
        | Term 
 
        | Respiratory ______ nearly always occurs at some stage of salicylate poisoning due to the direct stimulation of respiration. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The indirect effect on respiration by Salicylates is due to salicylate-induced _____________. |  | Definition 
 
        | uncoupling of oxidative phosphorylation |  | 
        |  | 
        
        | Term 
 
        | High toxic doses of Salicylates _______ respiration. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | If the toxic dose is high enough, the salicylates depress the medulla and cause ______ and ________. |  | Definition 
 
        | central respiratory paralysis and circulatory collapse (vasomotor depression) |  | 
        |  | 
        
        | Term 
 
        | With salicylates SEVERE toxicity can cause respiratory _______ and metabolic ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | In infants and children, toxicity has usually developed beyond the initial phase of respiratory _____ before they are seen by the physician (respiratory _____ is then more commonly observed in children). |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Dehydration may occur due to _______ through the lungs during hyperventilation and salicylate-induced ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | ________ is the main adverse effect associated with normal aspirin usage. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Salicylates may induce _____ and _____ due to stimulation of gastric mucosal receptors and stimulation of the medullary chemoreceptor trigger zone. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The mechanism of salicylate-induced gastric bleeding and damage also involves inhibition of _______ synthesis. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | _____ & ________, which are inhibited by  salicylates serve as cytoprotective agents in the gastric mucosa. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | PGI2 and PGE2 serve as cytoprotective agents in the gastric mucosa by inhibiting _______, increasing ________, and enhancing __________. |  | Definition 
 
        | inhibit acid secretion, increase mucosal blood flow, and enhance secretion of protective gastric mucous. |  | 
        |  | 
        
        | Term 
 
        | ______ excretion is altered by salicylates. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Low doses of salicylates (2 g or less) decrease urate excretion by _________. |  | Definition 
 
        | competing with urate for the organic acid secretory mechanism. |  | 
        |  | 
        
        | Term 
 
        | Inhibition of prostaglandin synthesis by salicylates can lead to decreased/increased renal blood flow. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | In toxic doses (>>2 g per day), salicylates produce CNS _______, followed by ________. |  | Definition 
 
        | stimulation (including convulsions) 
 depression
 |  | 
        |  | 
        
        | Term 
 
        | Primary CNS symptoms of toxic doses of salicylates: ___________. |  | Definition 
 
        | dizziness, tinnitus, high tone deafness |  | 
        |  | 
        
        | Term 
 
        | Orally ingested salicylates are ______ absorbed, partly from the _____ and mostly from the _______. |  | Definition 
 
        | rapidly 
 stomach
 
 small intestine
 |  | 
        |  | 
        
        | Term 
 
        | Salicylates rapidly distribute throughout the body, primarily by _______. |  | Definition 
 
        | pH-dependent passive diffusion. |  | 
        |  | 
        
        | Term 
 
        | Salicylate is _____ bound to plasma proteins. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Metabolism of salicylates takes place primarily in the liver ______ system and mitochondria. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The primary metabolites of salicylates are conjugates with _______ and ______ acid. |  | Definition 
 
        | glycine (salicyluric acid) 
 glucuronic (glucuronide)
 |  | 
        |  | 
        
        | Term 
 
        | Salicylate metabolism demonstrates _______ kinetics. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | For Salicylates, at high and toxic doses metabolism occurs according to _____ order kinetics, while at lower doses metabolism proceeds according to ____ order kinetics |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | *The half-life for salicylate is _______ hours in low doses and ______ hours at high doses. |  | Definition 
 
        | 3 to 6 
 15 to 30 (due to 0 order kinetics)
 |  | 
        |  | 
        
        | Term 
 
        | Salicylate is excreted in the _____ as the free compound and as ______. |  | Definition 
 
        | urine 
 conjugated metabolites
 |  | 
        |  | 
        
        | Term 
 
        | The amount of unchanged salicylate excreted may vary between 10% (_____ urine) and 85% (______ urine). |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Excretion of the metabolites is pH _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | _______ of the urine markedly enhance salicylate clearance. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Mild chronic salicylate intoxication occurring after repeated administration of high doses (>> 2g) is termed _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | In severe toxic overdoes of salicylates _____thermia is usually present and dehydration often occurs. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Treatment of severe salicylate poisoning must be _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | For severe salicylate poisoning, gastric lavage or induction of emesis will prevent further absorption if performed within a reasonable time after ingestion. ______ may be given to adsorb drug left in the stomach. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | An association exists between the administration of aspirin to children with __________ and concomitant development of _______ with severe ______ and ______. |  | Definition 
 
        | acute febrile illness (influenza and chicken pox) 
 Reye's syndrome
 
 severe hepatic injury and encephalopathy
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Acetaminophen (Tylenol) is an alternative to aspirin for ______ and ______ properties |  | Definition 
 
        | analgesic and antipyretic |  | 
        |  | 
        
        | Term 
 
        | Acetaminophen (Tylenol) is ineffective as a ________agent and is not considered useful as sole long-term therapy in _______. |  | Definition 
 
        | anti-inflammatory 
 rheumatic disease
 |  | 
        |  | 
        
        | Term 
 
        | Acetaminophen, in acute overdosage, acetaminophen can cause fatal _____. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Unlike asprin Acetaminophen produces little or no effect on: ________. |  | Definition 
 
        | respiration, cardiovascular function, acid-base balance, platelet aggregation, or uric acid excretion, gastric irritation, erosion and bleeding characteristic of aspirin. |  | 
        |  | 
        
        | Term 
 
        | Acetaminophen's half life is ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Acetaminophen's metabolism occurs by way of liver microsomal enzymes primarily by __________. |  | Definition 
 
        | the conjugating of glucuronic acid and sulfuric acid (as opposed to glycine with asprin). |  | 
        |  | 
        
        | Term 
 
        | In acute overdose, acetaminophen produces a dose-_______, potentially fatal_______. |  | Definition 
 
        | dependent 
 hepatic necrosis
 |  | 
        |  | 
        
        | Term 
 
        | Normally, acetaminophen is conjugated either as a ______ or a _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Normally, acetaminophen is conjugated either as a sulfate or a glucuronide, but with toxic doses, this system is ______ and microsomal enzymes produce other metabolites which can bind _______ groups on cell constituents. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The toxic metabolites the build up following acute overdose or acetaminophen are normally inactivated by ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | If glutathione stores are depleted by large amounts of metabolites resulting from toxic doses of acetaminophen, then ______ damage ensues. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The hepatotoxicity caused by acetaminophen is immediate/delayed. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | In toxic overdose of acetaminophen, GI symptoms reside _____ hours after ingestion. However, after _____ hours, hepatic enzymes, bilirubin, and prothrombin time become abnormal as hepatic injury occurs. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Protection against hepatic damage from acetaminophen overdose may be obtained by early administration of _____ compounds, ________ (________drug name) to inactivate the toxic metabolites. |  | Definition 
 
        | sulfhydryl 
 N-Acetylcysteine (Mucomyst, Mucosol)
 |  | 
        |  | 
        
        | Term 
 
        | N-Acetylcysteine (Mucomyst, Mucosol) is effective if given less than ____ hours after ingestion of toxic doses of acetaminophen. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Naproxen, an NSAID is unique in that it has a _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | __________ (_________), is a new class of NSAIDs that are COX-2 SELECTIVE AGENTS. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Celecoxib exhibits ______ activity. |  | Definition 
 
        | anti-inflammatory, antipyretic, and analgesic activity |  | 
        |  | 
        
        | Term 
 
        | The mechanism of action of Celecoxib is inhibition of ______ synthesis, primarily via inhibition of __________. |  | Definition 
 
        | prostaglandin (Not TX also) 
 cyclooxygenase-2
 |  | 
        |  | 
        
        | Term 
 
        | Celecoxib does not inhibit the cyclooxygenase-_ isoenzyme. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Clinical trials indicate that Celecoxib appears to be as effective as other NSAIDS in treating _______ and ______. |  | Definition 
 
        | osteoarthritis and rheumatoid arthritis |  | 
        |  | 
        
        | Term 
 
        | In short-term studies, celecoxib caused significantly fewer _______ than other NSAIDS and did not increase _______, consistent with a lack of COX-1 inhibition. |  | Definition 
 
        | gastrointestinal ulcers 
 bleeding time
 |  | 
        |  | 
        
        | Term 
 
        | Celecoxib is ___% bound to protein |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Celecoxib is metabolized hepatically by _________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Celecoxib metabolites are excreted in _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Celecoxib half life: ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Main adverse effect of Celecoxib? |  | Definition 
 
        | Prothrombotic effect: may increase the chance for MI in certain patients. |  | 
        |  | 
        
        | Term 
 
        | THERAPEUTIC INDEX = _____. |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | ANTAGONISM example: _______ |  | Definition 
 
        | BACTERIOSTATIC + BACTERICIDAL |  | 
        |  | 
        
        | Term 
 
        | Exception to the antagonism  of BS + BC: ________. |  | Definition 
 
        | ***PENICILLILN + CLINDAMYCIN |  | 
        |  | 
        
        | Term 
 
        | ANTIBIOTIC COMBINATIONS advantages:_______. |  | Definition 
 
        | ENHANCE THERAPEUTIC (MUTATION): TB 
 DELAY RESISTANCE RELATED TOXICIT
 
 DECREASE DOSE RELATED TOXICITY
 |  | 
        |  | 
        
        | Term 
 
        | AMINOGLYCOSIDE + _________ can enhance be used to enhance cell penetration and extension to gram +. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | ERYTHROMYCIN spectrum: _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | AMINOGLYCOSIDES spectrum: _______. |  | Definition 
 
        | - (+ also if combined with low dose penicillin) |  | 
        |  | 
        
        | Term 
 
        | CLINDAMYCIN spectrum: _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | TETRACYCLINES spectrum: _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | CHLORAMPHENICOL spectrum: _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | NATURAL (INTRINSIC) RESISTANCE types: ________. |  | Definition 
 
        | NON - SUSCEPTIBLE METABOLISM 
 DESTROYS DRUG (ex. PENICILLINASE)
 
 INABILITY OF DRUG TO PENETRATE
 |  | 
        |  | 
        
        | Term 
 
        | Example of NON - SUSCEPTIBLE METABOLISM, NATURAL (INTRINSIC) RESISTANCe? |  | Definition 
 
        | FOLIC ACID AS PRE - FORMED VITAMIN |  | 
        |  | 
        
        | Term 
 
        | ACQUIRED RESISTANCE types: _______. |  | Definition 
 
        | MUTATION ADAPTATION: BIOCHEMICAL INDUCTION (LOW DOSE)
 INFECTIOUS DRUG RESISTANCE
 |  | 
        |  | 
        
        | Term 
 
        | INFECTIOUS DRUG Aquired RESISTANCE sources: _______. |  | Definition 
 
        | *R – FACTORS: CONJUGATION 
 BACTERIOPHAGES – TRANSDUCTION
 
 TRANSPOSITION
 |  | 
        |  | 
        
        | Term 
 
        | Conjugation Resistance is a big factor for __________. |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | SUPERINFECTION  DEF: ___________ |  | Definition 
 
        | REPLACEMENT (NEW) INFECTION |  | 
        |  | 
        
        | Term 
 
        | CELEBREX (NSAID) is a ______ drug. So if you are allergic to it you will be sensitive to ______. |  | Definition 
 
        | Sulfa (-SO2-NH) 
 Sulfonamides
 |  | 
        |  | 
        
        | Term 
 
        | Two main antibiotic missuses: ________. |  | Definition 
 
        | *UNTREATABLE INFECTIONS (VIRUS) 
 *FEVER OF UNDETERMINED ORIGIN
 |  | 
        |  | 
        
        | Term 
 
        | SULFONAMIDES chemical group _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | SULFONAMIDE derivatives are made by attaching an R group to ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | No change in the ______ of SULFONAMIDES is tolerated. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | If the NH2 group of the other end of SULFONAMIDES (opposite of the SO2-NH2) is replaced by COOH, H, OH, alkyll ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Original SULFANILAMIDE drug (2 SULFANILAMIDEs linked): _______. |  | Definition 
 
        | PRONTOSIL (not used anymore) |  | 
        |  | 
        
        | Term 
 
        | PRONTOSIL is a _____ drug and must be ______. |  | Definition 
 
        | pro 
 metabolized to active form
 |  | 
        |  | 
        
        | Term 
 
        | PRONTOSIL is a prodrug that is metabolized into its active metabolite by  _______, which cleaves _______ to release ________. |  | Definition 
 
        | Liver 
 The double bond between the two Nitrogen groups to release two molecules of sulfanilmide
 |  | 
        |  | 
        
        | Term 
 
        | SULFANILAMIDEs are _______ inhibitors of ________. |  | Definition 
 
        | competitive 
 PABA (para-Aminobenzoic Acid)
 |  | 
        |  | 
        
        | Term 
 
        | Sulfanilamides adhere to ________, the ________ concept. |  | Definition 
 
        | WOODS - FILES THEORY 
 ANTIMETABOLITE CONCEPT
 |  | 
        |  | 
        
        | Term 
 
        | Sulfanilamides disrupt metabolic pathways by mimicking ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | In order for Sulfanilamides to inhibit growth the organism must: ______. |  | Definition 
 
        | Not absorb FA (Folic Acid) Not require an external source (FA)
 Synthessize FA
 |  | 
        |  | 
        
        | Term 
 
        | Sulfanilamides blocks the incorporation of _______ by the _______ enzyme. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | COUPLING enzyme aka ____________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | RESISTANCE TO THE Sulfanilamides mechanisms: __________. |  | Definition 
 
        | 1) DECREASED PERMEABILITY AND TRANSPORT 2) GENETIC CHANGES: COUPLING ENZYME (decreased affinity for Sulfanilamides and increased affinity for PABA) 3) Increased PRODUCTION OF PABA |  | 
        |  | 
        
        | Term 
 
        | There exists different _______ of Folic Acid. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | In addition to different oxidation states ,different ______ can be linked to _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | REACTIONS INVOLVING FH4: __________. |  | Definition 
 
        | Purine synthesis Thymine synthesis*
 Methionine synthesis*
 Serine synthesis
 |  | 
        |  | 
        
        | Term 
 
        | Sulfanilamides distribution: ________. |  | Definition 
 
        | ALL TISSUES: PLEURAL, PERITONEAL, SYNOVIAL, OCULAR FLUIDS, CSF |  | 
        |  | 
        
        | Term 
 
        | Sulfanilamides: ______ plasma proteins. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What is active, bound or free drug? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Sulfanilamides excretion: ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Sulfanilamides T1/2 is dependent on ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | For Sulfanilamides, does kidney function affect dosage? |  | Definition 
 
        | Yes, decrease with disease |  | 
        |  | 
        
        | Term 
 
        | Sulfanilamides is metabolized by the _________ by ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Sulfanilamides once acetylated in the liver _______ function and ______ toxic potential. |  | Definition 
 
        | loses biological function but maintains toxic potenital |  | 
        |  | 
        
        | Term 
 
        | Sulfanilamides solubility ______ in acidic urine and ______ in alkaline urine. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | A rare problem associated with Sulfanilamides and the kidneys is _________. |  | Definition 
 
        | CRYSTALLURIA HEMATURIA OBSTRUCTION |  | 
        |  | 
        
        | Term 
 
        | CRYSTALLURIA HEMATURIA OBSTRUCTION following Sulfanilamides admin is treated with ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | TRISULFAPYRIMIDINES is a TRIPLE SULFONAMIDE and gets around the solubility issue with CRYSTALLURIA HEMATURIA OBSTRUCTION by _______. |  | Definition 
 
        | Combining 3 sulfa drugs so to lower their individual doses |  | 
        |  | 
        
        | Term 
 
        | SULFONAMIDE main complication: ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | HEMATOLOGICAL complications can arise from Sulfanilamides because _______. |  | Definition 
 
        | if a patient is deficient in G6PDH, there will be an increase in hemolytic reactions and anemia, bc they cannot reduce the GLUTATHIONE necessary for RBC structure. |  | 
        |  | 
        
        | Term 
 
        | A rare, .1% side effect of Sulfanilamides   is ________, resulting in ________. |  | Definition 
 
        | AGRANULOCYTOSIS 
 LEUKOPENIA
 |  | 
        |  | 
        
        | Term 
 
        | Sulfanilamides can cause hemolysis because they are ______ drugs and ______ GLUTATHIONE. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Acetylation of Sulfanilamides makes them more or less soluble, and therefore ________ CRYSTALLURIA. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Best way to prevent CRYSTALLURIA with Sulfanilamides is to __________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Sulfanilamides have ______ half lives. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Because of their long half lives, Sulfanilamides, can have ________, which is characterized as ________. |  | Definition 
 
        | STEVENS - JOHNSON SYNDROME 
 a HYPERSENSITIVITY RX, with ERYTHEMA, MULTIFORME, and BLISTERING OF MUCOUS MEMBRANES
 |  | 
        |  | 
        
        | Term 
 
        | Sulfanilamides have GI complications of __________, resulting from __________. |  | Definition 
 
        | bowel bleeding 
 Reduced Vitamin K synthesis, required for the prothrombin factors, VII IX and X, the Sulfanilamides kill off the Vit K synthesizing bacteria of the bowel.
 |  | 
        |  | 
        
        | Term 
 
        | Sulfonamides have a drug interaction with ______ in neonates where it ______. |  | Definition 
 
        | Bilirubin 
 displaces the bilirubin bound, called KERNICTERUS
 |  | 
        |  | 
        
        | Term 
 
        | Bc of its high plasma binding Sulfonamides can elicit a __________ effect by displacing ____________, decreasing ______ synthesis, and inhibiting ________ metabolism. |  | Definition 
 
        | HYPOPROTHROMBINEMIC 
 BOUND WARFARIN
 
 Vit K
 
 Warfin
 |  | 
        |  | 
        
        | Term 
 
        | Sulfonamides displace ______ drug and therefore its doses need to be lowered. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Sulfonamides increase the half life of _______, by competing for _______. |  | Definition 
 
        | PHENYTOIN 
 Microsomal enzymes of the liver for metabolism
 |  | 
        |  | 
        
        | Term 
 
        | Phenytoin- anti seizure medicine WIKI 
 half life increased by Sulfonamides
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | ______ is an NSAID that has a sulfa group and therefore has cross reactivity with individuals who are allergic to Sulfonamides |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | ***Primary use of Sulfonamides? |  | Definition 
 
        | combined with TRIMETHOPRIM to treat UTI |  | 
        |  | 
        
        | Term 
 
        | Sulfonamides used to treat: __________. |  | Definition 
 
        | *NOCARDIOSIS *Shigella *Chlamydia *PNEUMOCYTIS JIROVECI (pneumonia) *TOXOPLASMA |  | 
        |  | 
        
        | Term 
 
        | Sulfanilamides solubility ______ in acidic urine and ______ in alkaline urine. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | A rare problem associated with Sulfanilamides and the kidneys is _________. |  | Definition 
 
        | CRYSTALLURIA HEMATURIA OBSTRUCTION |  | 
        |  | 
        
        | Term 
 
        | CRYSTALLURIA HEMATURIA OBSTRUCTION following Sulfanilamides admin is treated with ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | TRISULFAPYRIMIDINES is a TRIPLE SULFONAMIDE and gets around the solubility issue with CRYSTALLURIA HEMATURIA OBSTRUCTION by _______. |  | Definition 
 
        | Combining 3 sulfa drugs so to lower their individual doses |  | 
        |  | 
        
        | Term 
 
        | SULFONAMIDE main complication: ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | HEMATOLOGICAL complications can arise from Sulfanilamides because _______. |  | Definition 
 
        | if a patient is deficient in G6PDH, there will be an increase in hemolytic reactions and anemia, bc they cannot reduce the GLUTATHIONE necessary for RBC structure. |  | 
        |  | 
        
        | Term 
 
        | A rare, .1% side effect of Sulfanilamides   is ________, resulting in ________. |  | Definition 
 
        | AGRANULOCYTOSIS 
 LEUKOPENIA
 |  | 
        |  | 
        
        | Term 
 
        | Sulfanilamides can cause hemolysis because they are ______ drugs and ______ GLUTATHIONE. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Acetylation of Sulfanilamides makes them more or less soluble, and therefore ________ CRYSTALLURIA. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Best way to prevent CRYSTALLURIA with Sulfanilamides is to __________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Sulfanilamides have ______ half lives. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Because of their long half lives, Sulfanilamides, can have ________, which is characterized as ________. |  | Definition 
 
        | STEVENS - JOHNSON SYNDROME 
 a HYPERSENSITIVITY RX, with ERYTHEMA, MULTIFORME, and BLISTERING OF MUCOUS MEMBRANES
 |  | 
        |  | 
        
        | Term 
 
        | Sulfanilamides have GI complications of __________, resulting from __________. |  | Definition 
 
        | bowel bleeding 
 Reduced Vitamin K synthesis, required for the prothrombin factors, VII IX and X, the Sulfanilamides kill off the Vit K synthesizing bacteria of the bowel.
 |  | 
        |  | 
        
        | Term 
 
        | The Sulfonamide, Sulfasalazine is used to treat ________ & _________. |  | Definition 
 
        | ULCERATIVE COLITIS 
 RHEUMATOID ARTHRITIS
 |  | 
        |  | 
        
        | Term 
 
        | The Sulfonamide, Sulfasalazine is used to treat ULCERATIVE COLITIS using the _______ component and to treat RA using the ________ component. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Sulfasalazine has an antiinflammatory component, ___________. |  | Definition 
 
        | 5 -AMINOSALICYLIC ACID (5-ASA) |  | 
        |  | 
        
        | Term 
 
        | Sulfasalazine is split at its _____ bond into two active components, _______ & ______. |  | Definition 
 
        | DIAZO BOND (double bond between two N's) 
 SULFAPYRIDINE & 5-AMINOSALICYLIC ACID
 |  | 
        |  | 
        
        | Term 
 
        | Sulfonamides are administered _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | **Sulfonamides have a synergestic effect with __________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | All Sufa agents risk the development of ______ syndrome, especially those with _____, such as _______. |  | Definition 
 
        | STEVENS – JOHNSON SYN 
 long half lives
 
 SULFADOXINE
 |  | 
        |  | 
        
        | Term 
 
        | FH4 is used in the conversion of ______ to _____ for DNA synthesis. |  | Definition 
 
        | Uracil to Thymidine 
 (dUMP to dTMP)
 |  | 
        |  | 
        
        | Term 
 
        | A methyl group from FH4 is required for the activation of ________, which is responsible for the __________. |  | Definition 
 
        | METHIONINE-tRNAF (inactive) -> FORMYL METHIONINE-tRNAF (active) 
 Initiation of protein synthesis
 |  | 
        |  | 
        
        | Term 
 
        | ________ is an example of a large molecule antifolate. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Methotrexate's effect is due to the ________ theory. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Methotrexate is too ______ to be used as a __________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Methotrexate can be used in acute high doses to be used as a ________ agent and treat: _______. |  | Definition 
 
        | Antineoplastic agent 
 - ACUTE LYMPHOCYTIC LEUKEMIA
 – CHORIOCARCINOMA
 - BURKITT’S LYMPHOMA
 |  | 
        |  | 
        
        | Term 
 
        | Methotrexate can be used in low dose chronic for treating: __________. |  | Definition 
 
        | PSORIASIS / R. ARTHRITIS 
 IMMUNOSUPPRESSION
 |  | 
        |  | 
        
        | Term 
 
        | METHOTREXATE toxicity ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | High doses of METHOTREXATE used for cancer treatment toxicities: ________. |  | Definition 
 
        | **GI ulcers **BONE MARROW DEPRESSION
 **NEPHROTOXICITY
 |  | 
        |  | 
        
        | Term 
 
        | High doses of METHOTREXATE used for cancer treatment can be fatal, unless treated with the antidote, ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Low doses of METHOTREXATE used for RA/PSORIASIS & Immunosuppresion treatment toxicities: ________. |  | Definition 
 
        | **LIVER (HEPATIC FIBROSIS / CIRRHOSIS) *LUNG (PNEUMONITIS - RARE) **BONE MARROW / GI (ulcers) = RAPIDLY DIVIDING CELLS
 |  | 
        |  | 
        
        | Term 
 
        | Chronic METHOTREXATE treatment is supplemented with _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Acute METHOTREXATE treatment is supplemented with _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Two classes of Small Molecule Antifolates: __________. |  | Definition 
 
        | ANTI-MALARIAL- Pyrimethamine & Chloroguanide 
 ANTI-BACTERIAL- Trimethoprim
 |  | 
        |  | 
        
        | Term 
 
        | SMALL MOLECULE ANTIFOLATES serve as ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | SMALL MOLECULE ANTIFOLATES' spectrum is decided by __________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | SMALL MOLECULE ANTIFOLATES act as ANTIBACTERIAL agents through their ________. |  | Definition 
 
        | Inhibition of FOLATE REDUCTASE |  | 
        |  | 
        
        | Term 
 
        | Chloroguanide is a _______ drug that must be __________. |  | Definition 
 
        | Small Molecule Antifolate antimalrial pro drug 
 be metablized into its cyclic form to become active
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | DIHYDROFOLATE REDUCTASE uses ______ to reduce F or FH2. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Large molecule antifolates act at ____________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Small molecule antifolates act at ____________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Trimethroprim is a _______ type of drug and is good against _______. |  | Definition 
 
        | Small molecule antifolate 
 Bacteria
 |  | 
        |  | 
        
        | Term 
 
        | Methotrexate is a _______ type of drug and is good against _______. |  | Definition 
 
        | Large molecule antifolate 
 Humans
 |  | 
        |  | 
        
        | Term 
 
        | Pyrimethamine is a _______ type of drug and is good against _______. |  | Definition 
 
        | Small molecule antifolate 
 Malria
 |  | 
        |  | 
        
        | Term 
 
        | The addition of _______ on Antifolates cause their inhibition of DIHYDROFOLATE REDUCTASE to _______. |  | Definition 
 
        | HYDROPHOBIC SIDECHAINS 
 Increase
 |  | 
        |  | 
        
        | Term 
 
        | Main toxicity of small molecule antifolates: __________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Which of the  small molecule antifolates, cause MEGALOBLASTIC ANEMIA? |  | Definition 
 
        | PYRIMETHAMINE 
 TRIMETHOPRIM
 |  | 
        |  | 
        
        | Term 
 
        | What are less  toxic, large or small molecule antifolates? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | BACTERIAL RESISTANCE against small molecule antifolate arises from? |  | Definition 
 
        | INCREASE IN FOLATE REDUCTASE |  | 
        |  | 
        
        | Term 
 
        | Sulfas prevent FH4 synthesis by ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Antifolates prevent FH4 synthesis by ________. |  | Definition 
 
        | binding dihydrofolate reductase |  | 
        |  | 
        
        | Term 
 
        | Synergestic effect occurs between Sulfas and________. |  | Definition 
 
        | Tyimethoprim (small molecule antifolate) |  | 
        |  | 
        
        | Term 
 
        | For Sulfa + Tyimethoprim (small molecule antifolate) _______ organ is important because _____. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Sulfa + Tyimethoprim (small molecule antifolate) toxicity: ________. |  | Definition 
 
        | **URINARY TRACT INFECTIONS *PROSTATITIS
 |  | 
        |  | 
        
        | Term 
 
        | In addition to Sulfa + Tyimethoprim, another synergistic effect exists for antimalarial- ________ + _______. |  | Definition 
 
        | PYRIMETHAMINE (Small Mol Antifolate)+ SULFADIAZINE |  | 
        |  | 
        
        | Term 
 
        | Inhibitors of DNA Synthesis: ______. |  | Definition 
 
        | QUINOLONES, FLUOROQUINOLONES |  | 
        |  | 
        
        | Term 
 
        | FLUOROQUINOLONES INHIBIT ________ OR ________. |  | Definition 
 
        | DNA GYRASE (TOPOISOMERASE II) 
 TOPOISOMERASE IV
 |  | 
        |  | 
        
        | Term 
 
        | FLUOROQUINOLONES types: ____________. |  | Definition 
 
        | –**CIPROFLOXACIN (CIPRO®) –**LEVOFLOXACIN (LEVAQUIN®)
 |  | 
        |  | 
        
        | Term 
 
        | Inhibition of _________ by FLUOROQUINOLONES targets gram -. |  | Definition 
 
        | TOPOISOMERASE II (DNA GYRASE) |  | 
        |  | 
        
        | Term 
 
        | Inhibition of _________ by FLUOROQUINOLONES targets gram +. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | EUKARYOTIC CELLS -> NO _______ (with respect to FLUOROQUINOLONES). |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | FLUOROQUINOLONES are used in the treatment of: __________. |  | Definition 
 
        | *same as sulfa drugs *URINARY TRACT PATHOGENS
 *PROSTATITIS *SEXUALLY TRANSMITTED DISEASES
 *GI AND ABDOMINAL INFECTIONS
 *RESPIRATORY TRACT INFECTIONS (SERIOUS)
 
 **BONE, JOINT AND SOFT TISSUE INFECTIONS
 ** Anthrax
 |  | 
        |  | 
        
        | Term 
 
        | Problem with FLUOROQUINOLONES use? |  | Definition 
 
        | Been used extensively in CHICKEN / CATTLE FEED |  | 
        |  | 
        
        | Term 
 
        | FLUOROQUINOLONES activity is decreased by _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | *FLUOROQUINOLONES are metabolized by ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | FLUOROQUINOLONES, ________ decrease absorption, because they _________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | FLUOROQUINOLONES toxicity: ______. |  | Definition 
 
        | **GI **CRYSTALLURIA (Rare)
 ** decrease CYT P450 ( therefore increase CAFFEINE, THEOPHYLLINE)
 ***TENDINITIS
 ***CARTILEGE DAMAGE
 |  | 
        |  | 
        
        | Term 
 
        | Because of the ***CARTILEGE DAMAGE associated with FLUOROQUINOLONES, FLUOROQUINOLONES are _________. |  | Definition 
 
        | Not recommended for CHILDREN / FETUS / PREGNANCY |  | 
        |  | 
        
        | Term 
 
        | URINARY ANTISEPTIC drug: ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | NITROFURANTOIN excretion? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | NITROFURANTOIN have no ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | NITROFURANTOIN is only used to treat ________. |  | Definition 
 
        | CHRONIC LOWER URINARY TRACT INFECTIONS |  | 
        |  | 
        
        | Term 
 
        | NITROFURANTOIN is administered in ______. |  | Definition 
 
        | for MONTHS (14 DAY INTERVALS) |  | 
        |  | 
        
        | Term 
 
        | NITROFURANTOIN are not to be used for individuals that _________. |  | Definition 
 
        | Have severe renal insufficiency |  | 
        |  | 
        
        | Term 
 
        | NITROFURANTOIN spectrum: _______. |  | Definition 
 
        | Broad, many +/- but not P. AERUGINOSA, PROTEUS |  | 
        |  | 
        
        | Term 
 
        | NITROFURANS side effects: ________. |  | Definition 
 
        | **GASTROINTESTINAL EFFECT HEMATOLOGICAL REACTIONS
 (HEMOLYTIC ANEMIA – if low in G6PDH)
 |  | 
        |  | 
        
        | Term 
 
        | Three main FLUOROQUINOLONES side effects: _______. |  | Definition 
 
        | **GASTROINTESTINAL EFFECTS **DAMAGE TO GROWING CARTILAGE
 ***TENDINITIS -> TENDON RUPTURE
 |  | 
        |  | 
        
        | Term 
 
        | PENICILLIN structure is two rings: ________. |  | Definition 
 
        | Beta-Lactam Ring 
 Thiazolidine Ring
 |  | 
        |  | 
        
        | Term 
 
        | PENICILLIN acidic or basic? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Penicillins are formed by _______> |  | Definition 
 
        | Adding R groups to the NH2 of 6-aminopenicillanic acid |  | 
        |  | 
        
        | Term 
 
        | PENICILLIN R group determines: ________. |  | Definition 
 
        | – ANTIBACTERIAL SPECTRUM – ACID STABILITY
 – STABLE TO LACTAMASE
 |  | 
        |  | 
        
        | Term 
 
        | PENICILLIN G's problem of a short T1/2 was because it _______. |  | Definition 
 
        | Was rapidly cleared by the kidneys |  | 
        |  | 
        
        | Term 
 
        | PENICILLIN G's short half life was solved by _________. |  | Definition 
 
        | Combining it with another acid to decrease its excretion |  | 
        |  | 
        
        | Term 
 
        | PENICILLIN G's short half life was solved by Combining it with ______ or ________ to decrease its excretion. |  | Definition 
 
        | PROBENECID (increases urate excretion for gout treatment) |  | 
        |  | 
        
        | Term 
 
        | PENICILLIN G ACID INSTABILITY made it unable to be ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | PENICILLIN G's ACID INSTABILITY problem was solved by the addition of ______. |  | Definition 
 
        | The addition of oxygen to its R group, PHENOXYACETIC ACID |  | 
        |  | 
        
        | Term 
 
        | PENICILLIN G's problem of penicillin resistant staph was solved by _______. |  | Definition 
 
        | Adding a different R group and forming METHICILLIN |  | 
        |  | 
        
        | Term 
 
        | PENICILLIN G's problem of a narrow spectrum (gram +) was solved by the addition of new R groups and formation of _______ and _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | _______ formed from Penicillin in the presence of ________, is used to treat Copper-Wilson;s disease. |  | Definition 
 
        | β – β - DIMETHYL CYSTEINE 
 Strong H+
 |  | 
        |  | 
        
        | Term 
 
        | When PENICILLIN's beta lactam ring is broken it forms ______ and gains a free _______, which can react with _______ to form ________. |  | Definition 
 
        | PENICILLOIC ACID 
 FREE -COOH
 
 Lysine on proteins
 
 HAPTEN
 |  | 
        |  | 
        
        | Term 
 
        | HAPTEN formation is an _________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | PENICILLINS ARE toxicity? |  | Definition 
 
        | PENICILLINS ARE REMARKABLY NONTOXIC |  | 
        |  | 
        
        | Term 
 
        | Although Penicillins may be relatively non-toxic they are relatively prone to __________. |  | Definition 
 
        | HYPERSENSITIVITY (10-15%) |  | 
        |  | 
        
        | Term 
 
        | Lethal component of Penicillin HYPERSENSITIVITY? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | IMMEDIATE REACTION of HYPERSENSITIVITY to Penicillin occurs when? and is characterized as? |  | Definition 
 
        | Within MINUTES 
 REAL SERIOUS
 |  | 
        |  | 
        
        | Term 
 
        | ACCELERATED REACTION of HYPERSENSITIVITY to Penicillin occurs when? and is characterized as? |  | Definition 
 
        | 30 MINUTES – 48 HOURS (FLUSH, ITCH) |  | 
        |  | 
        
        | Term 
 
        | DELAYED REACTION of HYPERSENSITIVITY to Penicillin occurs when? and is characterized as? |  | Definition 
 
        | SEVERAL DAYS TO SEVERAL WEEKS (ITCH, JOINT PAIN, FEVER) |  | 
        |  | 
        
        | Term 
 
        | TREATMENT OF SEVERE penicillin HYPERSENSITIVITY REACTIONS: _______. |  | Definition 
 
        | **EPINEPHRINE *DIPHENHYDRAMINE
 |  | 
        |  | 
        
        | Term 
 
        | ANAPHYLAXIS of HYPERSENSITIVITY REACTIONS  symptoms: _________. |  | Definition 
 
        | –***SUDDEN, SEVERE HYPOTENSION –***RAPID DEATH
 –***BRONCHOCONSTRICTION
 –***SEVERE ASTHMA
 |  | 
        |  | 
        
        | Term 
 
        | Narrow Spectrum Penicillins that are Gram +: ________. |  | Definition 
 
        | Penicillin G and Penicillin V |  | 
        |  | 
        
        | Term 
 
        | Beta Lactamase RESISTANT PENICILLINS: _________. |  | Definition 
 
        | OXACILLIN NAFCILLIN
 DICLOXACILLIN
 |  | 
        |  | 
        
        | Term 
 
        | Problem with the Beta Lactamase RESISTANT PENICILLINS (OXACILLIN, NAFCILLIN, DICLOXACILLIN) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | BROAD SPECTRUM PENICILLIN, _________ aka the amino penicilins. |  | Definition 
 
        | AMPICILLIN 
 AMINO penicillins
 |  | 
        |  | 
        
        | Term 
 
        | AMPICILLIN is a broad spectrum penicillin, bc unlike other penicillins it covers gram __ also. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The broad spectrum penicillin, AMPICILLIN, is not active against _______ & ______. |  | Definition 
 
        | –**PSEUDOMONAS –**KLEBSIELLA
 |  | 
        |  | 
        
        | Term 
 
        | Broad spectrum Penicillins: __________. |  | Definition 
 
        | AMPICILLIN AMOXICILLIN
 BACAMPICILLIN
 TICARCILLIN
 PIPERACILLIN
 |  | 
        |  | 
        
        | Term 
 
        | The broad spectrum penicillins disadvantage, __________. |  | Definition 
 
        | inactivated by β - LACTAMASES |  | 
        |  | 
        
        | Term 
 
        | BACAMPICILLIN, the broad spectrum penicillin, works by ______. |  | Definition 
 
        | freeing AMPICILLIN, broad spectrum, after ingestion |  | 
        |  | 
        
        | Term 
 
        | PIPERACILLIN & TICARCILLIN are used to treat ______ and _____, or just serious gram ___ infections. |  | Definition 
 
        | *EXCELLENT FOR PSEUDOMONAS **PICK UP KLEBSIELLA
 
 -
 |  | 
        |  | 
        
        | Term 
 
        | Pseudomonas aeruginosa is treated using combination drug therapy of _______ or _______ + an _______ or _______. |  | Definition 
 
        | TICARCILLIN OR PIPERACILLIN (broad spectrum pencillins) 
 
 AMINOGLYCOSIDE OR FLUOROQUINOLONE
 |  | 
        |  | 
        
        | Term 
 
        | PENICILLINS target the last enzyme in _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | D - CYCLOSERINE interferes with _______ by ________. |  | Definition 
 
        | cell wall synthesis 
 inhibiting Racemase and ligase preventing the formation of D-alanine-D-alanine
 |  | 
        |  | 
        
        | Term 
 
        | In order to form the D- ALANYL – D – ALANINE from L - ALANINE for bacterial cell walls, two enzymes are used: ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | D - CYCLOSERINE is used for _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Pencillin inhibits the __________ reaction between _______ and _____ of cell wall synthesis. |  | Definition 
 
        | TRANSPEPTIDATION REACTION 
 D - ALANINE and GLYCINE
 |  | 
        |  | 
        
        | Term 
 
        | Pencillin can inhibit the TRANSPEPTIDATION REACTION of gram_ bacteria. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Pencillin inhibits the transpeptidase reaction by _______. |  | Definition 
 
        | forming covalently bond to the enzyme |  | 
        |  | 
        
        | Term 
 
        | PENICILLIN inhibits the transpeptidase reaction by mimicking _________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | In addition to binding and inhibting the transpeptidase reaction, penicillin also binds ________ and activates _______. |  | Definition 
 
        | PENICILLIN – BINDING PROTEINS 
 AUTOLYTIC ENZYMES
 |  | 
        |  | 
        
        | Term 
 
        | β-LACTAMASE is located where for Gram +? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | β-LACTAMASE is located where for Gram -? |  | Definition 
 
        | Between wall and membrane |  | 
        |  | 
        
        | Term 
 
        | If penicillin binds PENCILLIN BINDING PROTEINS ________, it leads to _______. |  | Definition 
 
        | ACTIVATION OF AUTOLYTIC ENZYMES &
 INHIBITION of PEPTIDOGLYCAN SYNTHESIS
 |  | 
        |  | 
        
        | Term 
 
        | CEPHALOSPORINS are similar in structure to _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Advantage of CEPHALOSPORINS over Penicillins? |  | Definition 
 
        | **LESS SUSCEPTIBLE TO PENICILLINASE |  | 
        |  | 
        
        | Term 
 
        | CEPHALOSPORINS have a _______ spectrum. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | CEPHALOSPORINS have a broad spectrum and are used especially to treat ______, _____, and ______ |  | Definition 
 
        | – *PROTEUS (Broad Spectrum Penicillins innefective) – *E. COLI (Broad Spectrum Penicillins innefective)
 – *KLEBSIELLA
 |  | 
        |  | 
        
        | Term 
 
        | CEPHALOSPORINS mechanism of action? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Problem with the second generation of CEPHALOSPORINS? |  | Definition 
 
        | BLEEDING PROBLEMS &
 DISULFIRAM (nausea following drinking) both because the presence of (MTT = METHYL - TETRAZOLE - THIOMETHYL)
 |  | 
        |  | 
        
        | Term 
 
        | Each generation of CEPHALOSPORINS got better in which respect? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cephalosporin, ________, demonstrates excellent _______ and is not _______. |  | Definition 
 
        | CEFEPIME 
 *EXCELLENT CSF LEVELS
 
 HYDROLYSED BY β - LACTAMASES
 |  | 
        |  | 
        
        | Term 
 
        | CEFEPIME, a Cephalosporin, is used to treat: ___________. |  | Definition 
 
        | PSEUDOMONAS ENTEROBACTERIACEAE
 |  | 
        |  | 
        
        | Term 
 
        | In the third generation of Cephalosporins, they gained the ability to _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | CEPHALOSPORINS are all potentially _____ toxic. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | CEPHALOSPORINS are relatively non toxic, but should be cautious with _______ if ________. |  | Definition 
 
        | HYPERSENSITIVITY REACTIONS IF SEVERE RX TO PENICILLIN |  | 
        |  | 
        
        | Term 
 
        | CEPHALOSPORINS are _____ antibiotics. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | In addition to CEPHALOSPORINS, ______ & ______ are also beta-lactam antibiotics. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The CARBAPENEM, Impienem, is a ______ inhibitor. |  | Definition 
 
        | Cell wall inhibitor (eta-lactam antibiotics) |  | 
        |  | 
        
        | Term 
 
        | The Carbapenem,Impienem, has ______ spectrum. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The Carbapenem, Impienem, is used to treat: ______ infections. |  | Definition 
 
        | URINARY TRACT / LOWER RESPIRATORY ABDOMINAL / GYN
 |  | 
        |  | 
        
        | Term 
 
        | The Carbapenem, Impienem, must be administered with _______, because it _________. |  | Definition 
 
        | Cilastatin decreases renal tubular dihydropeptidase, which normally destroys Carbapenem |  | 
        |  | 
        
        | Term 
 
        | The Carbapenem, Impienem, has a _____ with penicillin. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The Carbapenem, Meropenem, is similar to _______, but does not _______. |  | Definition 
 
        | Impienem 
 require Cilastatin
 |  | 
        |  | 
        
        | Term 
 
        | The Carbapenem, Meropenem side effect? |  | Definition 
 
        | Cross allergy with Penicillin 
 (Carbapenem, which are Beta Lactam Antibio)
 |  | 
        |  | 
        
        | Term 
 
        | Carbapenems (Impienem/Meropenem ) are used for ___________. |  | Definition 
 
        | Last resort therapy: E. COLI
 KLEBSIELLA PNEUMONIAE
 |  | 
        |  | 
        
        | Term 
 
        | Monobactams is a type of _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Monobactams are only used to treat _______. |  | Definition 
 
        | Only gram - rods (PSEUDOMONAS) |  | 
        |  | 
        
        | Term 
 
        | Monobactams like other Beta-lactam antibiotics are ________. |  | Definition 
 
        | Resistant to many β - LACTAMASES |  | 
        |  | 
        
        | Term 
 
        | Monobactams unique advantage over other Beta-lactam antibiotics? |  | Definition 
 
        | *CAN USE WITH PENICILLIN SENSITIVE PATIENT |  | 
        |  | 
        
        | Term 
 
        | Beta-Lactamase Inhibitors: ________. |  | Definition 
 
        | Clavulanate (Clavulanic Acid) Sulbactam
 Tazobactam
 |  | 
        |  | 
        
        | Term 
 
        | Beta-Lactamase Inhibitors are combined with ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Beta-Lactamase Inhibitors extend the coverage of Penicillins to ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cycloserine is used to treat TB and it's MOA is inhibition of ________ and _______, leading to disruption of ______. |  | Definition 
 
        | Alanine Racemase 
 Alanine Ligase
 
 Cell Wall Synthesis
 |  | 
        |  | 
        
        | Term 
 
        | Vancomycin, mechanism of action: ________, which disrupts _______. |  | Definition 
 
        | *BINDS D – ALA – D – ALA 
 Cell wall synthesis
 |  | 
        |  | 
        
        | Term 
 
        | Vancomycin used to treat ________, especially for _______ & ________. |  | Definition 
 
        | Gram + 
 MRSA, CLOSTRIDIUM DIFFICILE (Both Gram +)
 |  | 
        |  | 
        
        | Term 
 
        | Vancomycin can be _____toxic. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Vancomycin can cause __________ syndrome, which is _____________ and is caused by __________. |  | Definition 
 
        | RED MAN SYNDROME 
 *ERYTHEMATOUS, URTICARIA, *FLUSHING, *TACHCARDIA, HYPOTENSION
 
 Histamine release from administered IV too quickly.
 |  | 
        |  | 
        
        | Term 
 
        | A major problem for Vancomycin resistance of is ________, which lead to ________ resistant bacteria. |  | Definition 
 
        | ALTERED D – ALA – D - ALA TARGET 
 VRSA (STAPH. AUREUS)
 |  | 
        |  | 
        
        | Term 
 
        | Vancomycin + _______ can have a synergestic effect on its Ototoxic property. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | _______ is similar to Vancomycin and acts as a __________ inhibitor. |  | Definition 
 
        | Teicoplanin 
 Cell wall syntehsis inhibitor
 |  | 
        |  | 
        
        | Term 
 
        | Teicoplanin's main treatment use is for: __________. |  | Definition 
 
        | STEOMYELITIS, ENDOCARDITIS caused by Methicillin and Endocarditis caused by methicillin-resistant and methicillin-susceptible Staph, Strep, and Enterococci |  | 
        |  | 
        
        | Term 
 
        | Teicoplanin can be combined with ______ when treating S. Aureus. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Bacitracin disrupts _______, by inhibiting _______. |  | Definition 
 
        | Interferes with transport across the membrane for molecules to be used in cell wall synthesis. Therefore it is a membrane inhibitor not a cell wall inhibitor. |  | 
        |  | 
        
        | Term 
 
        | Bacitracin is used to treat ________ and ________. |  | Definition 
 
        | Staph 
 Gram + infections that have not responded to other treatments
 |  | 
        |  | 
        
        | Term 
 
        | Bacitracin can be administered Intrathecal/Intrapleurally to treat ________. |  | Definition 
 
        | Resistant Staph Meningitis/ Empyema (pus in the body cavity) |  | 
        |  | 
        
        | Term 
 
        | Bacitracin possess serious _______toxicity, especially when given with ___________ and when administered _______, but not when administered _____. |  | Definition 
 
        | Nephrotoxicity 
 AG
 
 Parenteral
 
 Orally
 |  | 
        |  | 
        
        | Term 
 
        | A clinical problem with Bacitracin is it becomes nephrotoxic if it ___________, therefore it is primarily administered ________. |  | Definition 
 
        | enter systemic circulation 
 Topically
 |  | 
        |  | 
        
        | Term 
 
        | Polymyxin B Sulfate is a _________ (overall structure). |  | Definition 
 
        | Cyclic Poplypeptide Antibitoic |  | 
        |  | 
        
        | Term 
 
        | Polymyxin B Sulfate is a ________ that disrupts ________. |  | Definition 
 
        | Cationic detergent 
 Cell membranes
 |  | 
        |  | 
        
        | Term 
 
        | Polymyxin B Sulfate is administered ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Polymyxin B Sulfate exhibits extreme ______toxicity when administered ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Polymyxin B Sulfate is used to treat _______ and ______. |  | Definition 
 
        | Resistant Gram - 
 Pseudomonas in CF
 |  | 
        |  | 
        
        | Term 
 
        | Colistin sulfate is a ________ that disrupts ________. |  | Definition 
 
        | Cationic detergent 
 Cell membranes
 |  | 
        |  | 
        
        | Term 
 
        | Colistin sulfate is used to treat ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Colistin sulfate toxicity? |  | Definition 
 
        | Non unless administered parenterally (not recommended) |  | 
        |  | 
        
        | Term 
 
        | Polymyxin B and Colistin Sulfate are old antibiotics that are being used to treat ________. |  | Definition 
 
        | Emerging multiresistant gram - |  | 
        |  | 
        
        | Term 
 
        | Vancomycin, mechanism of action: ________, which disrupts _______. |  | Definition 
 
        | *BINDS D – ALA – D – ALA 
 Cell wall synthesis
 |  | 
        |  | 
        
        | Term 
 
        | Vancomycin used to treat ________, especially for _______ & ________. |  | Definition 
 
        | Gram + 
 MRSA, CLOSTRIDIUM DIFFICILE (Both Gram +)
 |  | 
        |  | 
        
        | Term 
 
        | Vancomycin can be _____toxic. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Vancomycin can cause __________ syndrome, which is _____________ and is caused by __________. |  | Definition 
 
        | RED MAN SYNDROME 
 *ERYTHEMATOUS, URTICARIA, *FLUSHING, *TACHCARDIA, HYPOTENSION
 
 Histamine release from administered IV too quickly.
 |  | 
        |  | 
        
        | Term 
 
        | A major problem for Vancomycin resistance of is ________, which lead to ________ resistant bacteria. |  | Definition 
 
        | ALTERED D – ALA – D - ALA TARGET 
 VRSA (STAPH. AUREUS)
 |  | 
        |  | 
        
        | Term 
 
        | Vancomycin + _______ can have a synergestic effect on its Ototoxic property. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | _______ is similar to Vancomycin and acts as a __________ inhibitor. |  | Definition 
 
        | Teicoplanin 
 Cell wall syntehsis inhibitor
 |  | 
        |  | 
        
        | Term 
 
        | Teicoplanin's main treatment use is for: __________. |  | Definition 
 
        | STEOMYELITIS, ENDOCARDITIS caused by Methicillin and Endocarditis caused by methicillin-resistant and methicillin-susceptible Staph, Strep, and Enterococci |  | 
        |  | 
        
        | Term 
 
        | Teicoplanin can be combined with ______ when treating S. Aureus. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Bacitracin disrupts _______, by inhibiting _______. |  | Definition 
 
        | Interferes with transport across the membrane for molecules to be used in cell wall synthesis. Therefore it is a membrane inhibitor not a cell wall inhibitor. |  | 
        |  | 
        
        | Term 
 
        | Bacitracin is used to treat ________ and ________. |  | Definition 
 
        | Staph 
 Gram + infections that have not responded to other treatments
 |  | 
        |  | 
        
        | Term 
 
        | Bacitracin can be administered Intrathecal/Intrapleurally to treat ________. |  | Definition 
 
        | Resistant Staph Meningitis/ Empyema (pus in the body cavity) |  | 
        |  | 
        
        | Term 
 
        | Daptomycin is similar to ______ and is used to treat ______ and _______. |  | Definition 
 
        | VANCOMYCIN 
 VANCOMYCIN- resistant Enterococci & Staph. Aureus
 |  | 
        |  | 
        
        | Term 
 
        | Daptomycin's MofA: _______. |  | Definition 
 
        | Depolarizes membrane and causes K efflux |  | 
        |  | 
        
        | Term 
 
        | Daptomycin is an alternative for _____. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | ______ can diminish the effects of oral contraceptives. |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | The incoming _______ binds at the Aminoacyl Site. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The peptide linkage is formed between the ____ and ____ site. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The peptide linkage between the P and A is catalyzed by _____ enzyme. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What is the name of the reaction when that follows the peptidyl transferase reaction and what happens? |  | Definition 
 
        | The translocation reaction 
 A site shifts to P side and next aminoacyl tRNA goes into A site
 |  | 
        |  | 
        
        | Term 
 
        | Erythromycin is a _______ type of antibiotic. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | A macrolide antibiotic is a ______ structure with ______ attached. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 3 macrolide antibiotics: ________. |  | Definition 
 
        | Erythromycin Clarithromycin
 Azithromycin
 |  | 
        |  | 
        
        | Term 
 
        | Erythromycin disrupts _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Erythromycin disrupts protein synthesis by ________. |  | Definition 
 
        | Inhibiting the incorporation of Amino Acids |  | 
        |  | 
        
        | Term 
 
        | Erythromycin binds to ________ in order to inhibit protein synthesis. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Erythromycin mainly inhibits the _____ step of protein synethesis. It also inhibits ______ (minor) and _______ by binding to ________. |  | Definition 
 
        | TRANSLOCATION STEP 
 Formation of initiation complex
 
 Peptidyl Transferase by binding to 23S rRNA
 |  | 
        |  | 
        
        | Term 
 
        | Erythromycin static/cydial? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Erythromycin's activity is dependent upon? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Erythromycin's activity increases at _____pHs. |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | In addition to Erythromycin's main targets of Gram +, what unique gram - can it also be used to treat? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The spectrum of Erythromycin is dependent upon ______. |  | Definition 
 
        | Penetration into the cell |  | 
        |  | 
        
        | Term 
 
        | Resistance to Erythromycin is through: __________. |  | Definition 
 
        | MUTATION – 50S (decrease binding) 
 EFFLUX BY ACTIVE PUMP
 
 HYDROLYSIS OF MACROLIDES
 
 INDUCED RESISTENCE – LOW DOSE
 |  | 
        |  | 
        
        | Term 
 
        | Resistance to Erythromycin is cross resistance with ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Why is the estolate form of Erythromycin no longer used? |  | Definition 
 
        | CHOLESTATIC HEPATITIS (10 - 12%) |  | 
        |  | 
        
        | Term 
 
        | The free/sterate form of Erythromycin's main side effect is _______. |  | Definition 
 
        | **Epigastric Distress (Nausea, Vomiting, diarrhea) |  | 
        |  | 
        
        | Term 
 
        | Erythromycin has good _______ and low ______ and becomes concentrated in _______. |  | Definition 
 
        | *GOOD BODY DISTRIBUTION *LOW IN CSF *CONCENTRATED IN LIVER |  | 
        |  | 
        
        | Term 
 
        | Erythromycin *H. PYLORI (PEPTIC ULCERS)is excreted __________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Erythromycin is excreted in the bile in its _____ form, because it is _________ in the liver. |  | Definition 
 
        | bile 
 concentrated in the liver
 |  | 
        |  | 
        
        | Term 
 
        | _______ excretion is low in Ertyhtromycin. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Ertyhtromycin dosage for kidney disease? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Ertyhtromycin dosage for liver disease? |  | Definition 
 
        | same dose (unless severely damaged) |  | 
        |  | 
        
        | Term 
 
        | Ertyhtromycin is the drug of choice for: _______. |  | Definition 
 
        | Mycoplasma Pneumoniae Legionella
 Diphtheria
 |  | 
        |  | 
        
        | Term 
 
        | Ertyhtromycin can be used as a substitute for _________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Ertyhtromycin can be used as a substitute for penicillin for those who are allergic for _______ & ______ infections. |  | Definition 
 
        | Strep infections 
 Staph infections
 |  | 
        |  | 
        
        | Term 
 
        | Clarithromycin is a _____ type of drug. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Clarithromycin is used to treat: __________. |  | Definition 
 
        | *H. INFLUENZE *MYCOBACTERIUM AVIUM (AIDS PATIENT)
 *H. PYLORI (PEPTIC ULCERS)
 |  | 
        |  | 
        
        | Term 
 
        | Azithromycin is a ______ type of drug. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Azithromycin is used to treat: __________. |  | Definition 
 
        | MYCOBACTERIUM AVIUM (AIDS) (Just like Clarithromycin) 
 TOXOPLASMOSIS ENCEPHALITIS (AIDS)
 
 URETHRITIS (CHYLAMYDIA TRACHOMATIS)
 |  | 
        |  | 
        
        | Term 
 
        | Telithromycin is a macrolide that can be used to treat __________. |  | Definition 
 
        | COMMUNITY- ACQUIRED PNEUMONIA |  | 
        |  | 
        
        | Term 
 
        | Macrolide main drug drug interactive? |  | Definition 
 
        | Decrease the activity of CYT P450 Increase the activity of other drugs
 |  | 
        |  | 
        
        | Term 
 
        | Which macrolides decrease CYT P450 and which have no affect? |  | Definition 
 
        | Decrease: Clarithromycin
 Ertyhtromycin
 
 AZITHROMYCIN
 |  | 
        |  | 
        
        | Term 
 
        | Erythromycin has good _______ and low ______ and becomes concentrated in _______. |  | Definition 
 
        | *GOOD BODY DISTRIBUTION *LOW IN CSF *CONCENTRATED IN LIVER |  | 
        |  | 
        
        | Term 
 
        | Erythromycin *H. PYLORI (PEPTIC ULCERS)is excreted __________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Erythromycin is excreted in the bile in its _____ form, because it is _________ in the liver. |  | Definition 
 
        | bile 
 concentrated in the liver
 |  | 
        |  | 
        
        | Term 
 
        | _______ excretion is low in Ertyhtromycin. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Ertyhtromycin dosage for kidney disease? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Ertyhtromycin dosage for liver disease? |  | Definition 
 
        | same dose (unless severely damaged) |  | 
        |  | 
        
        | Term 
 
        | Ertyhtromycin is the drug of choice for: _______. |  | Definition 
 
        | Mycoplasma Pneumoniae Legionella
 Diphtheria
 |  | 
        |  | 
        
        | Term 
 
        | Ertyhtromycin can be used as a substitute for _________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Ertyhtromycin can be used as a substitute for penicillin for those who are allergic for _______ & ______ infections. |  | Definition 
 
        | Strep infections 
 Staph infections
 |  | 
        |  | 
        
        | Term 
 
        | Clarithromycin is a _____ type of drug. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Clarithromycin is used to treat: __________. |  | Definition 
 
        | *H. INFLUENZE *MYCOBACTERIUM AVIUM (AIDS PATIENT)
 *H. PYLORI (PEPTIC ULCERS)
 |  | 
        |  | 
        
        | Term 
 
        | Azithromycin is a ______ type of drug. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Azithromycin is used to treat: __________. |  | Definition 
 
        | MYCOBACTERIUM AVIUM (AIDS) (Just like Clarithromycin) 
 TOXOPLASMOSIS ENCEPHALITIS (AIDS)
 
 URETHRITIS (CHYLAMYDIA TRACHOMATIS)
 |  | 
        |  | 
        
        | Term 
 
        | Types of Lincosamides: _______. |  | Definition 
 
        | Clindamycin 
 Clindamycin Phosphate
 |  | 
        |  | 
        
        | Term 
 
        | Lincosamides (Clindamycin & Clindamycin Phosphate) disrupt? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Lincosamides (Clindamycin & Clindamycin Phosphate) bind? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Lincosamides (Clindamycin & Clindamycin Phosphate) have an antagonist relationship with ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Lincosamides (Clindamycin & Clindamycin Phosphate) block the ______ step of protein synthesis. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Lincosamides (Clindamycin & Clindamycin Phosphate) have a ______ spectrum? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Lincosamides (Clindamycin & Clindamycin Phosphate) have spectrum similar to ERYTHROMYCIN, _______, but in addition it also is useful for _______ infections. |  | Definition 
 
        | Broad Spectrum 
 **ANAEROBIC INFECTIONS
 |  | 
        |  | 
        
        | Term 
 
        | Lincosamides (Clindamycin & Clindamycin Phosphate) can be used to treat severe anaerobic infections, such as ________. |  | Definition 
 
        | –** BACTEROIDES (RESP STRAINS) –** BACTEROIDES (GI STRAINS)
 |  | 
        |  | 
        
        | Term 
 
        | Clindamycin has cross resistance with _______. |  | Definition 
 
        | ERYTHROMYCIN (both bind 50s  and block the translocation step) |  | 
        |  | 
        
        | Term 
 
        | Clindamycin is metabolized by the __________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Clindamycin is excreted by the _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Clindamycin dose if liver disease? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Clindamycin dose if kidney disease? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | If poor kidney function, Clindamycin's ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Clindamycin's main toxicity? |  | Definition 
 
        | Selects for C. DIFFICILE and causes *PSEUDOMEMBRANEOUS ENTEROCOLITIS |  | 
        |  | 
        
        | Term 
 
        | Clindamycin's main toxicity is it selects for DIFFICILE and causes PSEUDOMEMBRANEOUS ENTEROCOLITIS, this can be treated with either _______ or _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Clindamycin is used for patients that are _________ and to treat ______. |  | Definition 
 
        | PENICILLIN (Just like ERYTHROMYCIN is) 
 Anaerobic infections
 |  | 
        |  | 
        
        | Term 
 
        | Clindamycin has an antagonist affect with _________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Tetracyclines are _______ spectrum. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Tetracycline drugs: __________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Tetracyclines bind ________ in order to distrupt. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Tetracycline inhibit the __________. |  | Definition 
 
        | Attachment of the amino-acyl tRNA to "A" site |  | 
        |  | 
        
        | Term 
 
        | Is there much difference between the spectrums of Tetracyclines? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Tetracylcine resistance is _______ mediated. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The main mechanisms of resistance against Tetracyclines is: __________. |  | Definition 
 
        | **+ENERGY – DEPENDENT increase in Efflux **RIBOSOME PROTECTION PROTEINS (can't reach ribosome)
 R+ Factor
 |  | 
        |  | 
        
        | Term 
 
        | Tetracylcine pharmokinetic drawback is __________, except for ________. |  | Definition 
 
        | Incomplete absorption 
 Doxycycline
 |  | 
        |  | 
        
        | Term 
 
        | Due to the incomplete absorption of Tetracylcines, complications: _______. |  | Definition 
 
        | 1) *ERRATIC BLOOD LEVELS 2) *RESIDUAL IN GI TRACT -> NAUSEA / VOMITING / GI IRRITATION
 3) *SUPERINFECTION
 |  | 
        |  | 
        
        | Term 
 
        | Tetracylcines' poor absorption can be partially attributed to _______, including: __________. |  | Definition 
 
        | CHELATORS 
 MILK PRODUCTS
 Iron
 ANTACIDS FOR ULCERS
 |  | 
        |  | 
        
        | Term 
 
        | Which Tetracyclines have long half life and which ones have short? |  | Definition 
 
        | Tetracycline short 
 Minocycline/Doxycycline Long
 |  | 
        |  | 
        
        | Term 
 
        | The Tetracyclines, DOXYCYCLINE / MINOCYCLINE, have a longer half life and thus a lower ________, than Tetracycline. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Tetracyclines can develop ______ toxicity which means you have to discontinue use. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | In addition to GI toxicity, Tetracyclines  have: ________ toxicities. |  | Definition 
 
        | PHOTOSENSITIVITY ONYCHOLYSIS (LOOSE NAILS) / PIGMENTATION OF THE NAILS
 *RENAL TOXICITY
 *TEETH: FLUORESCENCE DISCOLORATION
 *Bone: deformity
 DIZZINESS / VERTIGO – VESTIBULAR REACTIONS
 *SUPERINFECTION
 |  | 
        |  | 
        
        | Term 
 
        | The renal toxicity of Tetracyclines can cause __________, from the use of ________, which affects __________. |  | Definition 
 
        | Fanconi Syndrome 
 Outdated drugs
 
 Proximal Tubules
 |  | 
        |  | 
        
        | Term 
 
        | In patients with impaired kidney function, Tetracyclines __________, except for _________ and ________. |  | Definition 
 
        | Accumulate 
 Minocycline/Doxycycline
 |  | 
        |  | 
        
        | Term 
 
        | Why do Tetracyclines accumulate in impaired kidneys, while Minocycline/Doxycycline do not? |  | Definition 
 
        | The have low renal clearence |  | 
        |  | 
        
        | Term 
 
        | Tetracyclines can have toxic effects on the teeth by causing ______ and ______. |  | Definition 
 
        | FLUORESCENCE DISCOLORATION
 |  | 
        |  | 
        
        | Term 
 
        | Because of their ______ toxicity Tetracyclines, are not recommended for use in ________. |  | Definition 
 
        | Bone (deformities) 
 Children
 |  | 
        |  | 
        
        | Term 
 
        | With _______ use, Tetracyclines can cause _______ superinfections. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Tetracyclines effect on teeth is ______ discoloration. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Tetracyclines static or cidal? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Tetracyclines should not be combined with? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Tetracyclines + ________ or ______ or _______ increases the metabolism of Tetracyclines and therefore __________. |  | Definition 
 
        | CARBAMAZEPINE PHENOBARBITAL
 PHENYTOIN
 (Anti EPILEPSY agents)
 
 Reduces their half lives
 |  | 
        |  | 
        
        | Term 
 
        | Tetracylcines can diminish the effects of ________. |  | Definition 
 
        | Oral contraceptives (just like ampicillin) |  | 
        |  | 
        
        | Term 
 
        | Tetracylcines is the drug of choice for: _____________. |  | Definition 
 
        | Diseases caused by Rickettsia (RMSF) and Coxillea (Q Fever)
 
 Lyme Disease (Borrelia)
 |  | 
        |  | 
        
        | Term 
 
        | Lyme Disease Stages: __________. |  | Definition 
 
        | – 1) ERYTHEMA MIGRANS (RASH) – 2) NEUROLOGIC DISEASE
 – 3) CARDIAC DISEASE
 – 4) ARTHRITIS
 |  | 
        |  | 
        
        | Term 
 
        | ______ or ______ can be used to treat Lyme Disease. |  | Definition 
 
        | Doxycycline (Tetracylcine) or Amoxicillin |  | 
        |  | 
        
        | Term 
 
        | Tigecycline is a derivative of _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Tigecycline binds to _____. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Tigecycline binds to 30S and blocks _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Tigecycline toxicities: ________. |  | Definition 
 
        | NAUSEA, VOMITING, PHOTOSENSITIVITY, ELEVATED SERUM AMYLASE, HYPERBILIRUBINEMIA, ELEVATED BUN |  | 
        |  | 
        
        | Term 
 
        | Tigecycline is not for use in __________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Tigecycline is used to treat complicated ________ and ______ infections. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Tigecycline's main use is to treat _______. |  | Definition 
 
        | where other drugs have not been successful |  | 
        |  | 
        
        | Term 
 
        | Cholramphenicol binds ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cholramphenicol inhibits ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cholramphenicol also prevents _______ |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cholramphenicol disrupts:________ |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cholramphenicol can react with the ________ of Eukaryotic cells. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cholramphenicol spectrum? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cholramphenicol resistance is primarily from? |  | Definition 
 
        | ****INACTIVATION – ACETYLATION |  | 
        |  | 
        
        | Term 
 
        | The resistance against Cholramphenicol by acetylation is gained via ______ from the ________? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | If Cholramphenicol is acetylated it becomes ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The R-Factor Plasmid through acetylation grants resistance against: ______. |  | Definition 
 
        | CHLORAMPHENICOL, AMINOGLYCOSIDES (ALL), SULFONAMIDES |  | 
        |  | 
        
        | Term 
 
        | The R-Factor Plasmid through adenylation grants resistance against: ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The R-Factor Plasmid through phosphoryaltion grants resistance against: ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The R-Factor Plasmid through transporters grants resistance against: ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The R-Factor Plasmid through beta-lactamse grants resistance against: ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cholramphenicol has good _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Because of its good CSF levels Cholramphenicol can be used to treat ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cholramphenicol is metabolized by the ________ into _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | With liver disease______ the dose of Cholramphenicol. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | With kidney disease ______ the dose of Cholramphenicol. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cholramphenicol is excreted by ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Bc Cholramphenicol is a broad spectrum it can cause a _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cholramphenicols are metabolized by the liver via ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cholramphenicol in its Glucuronide form is ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | In neonates, Cholramphenicol toxicity can cause _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | In neonates, Cholramphenicol toxicity can cause ***GRAY BABY SYNDROME, which is a failure to form ________ with inadequate ________ leading to ________ and __________. |  | Definition 
 
        | GLUCURONIC ACID (used to metabolize) 
 RENAL EXCRETION
 
 HYPOTHERMIA / ACUTE VASCULAR COLLAPSE (40 % FATAL)
 |  | 
        |  | 
        
        | Term 
 
        | Cholramphenicol's main toxicity affects the _______ system by causing ________ or ________. |  | Definition 
 
        | Hematological 
 Transient bone marrow depression
 
 Aplastic anemia
 |  | 
        |  | 
        
        | Term 
 
        | Cholramphenicol transient bone marrow depression is dose unrelated/related and reversible/irreversible. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cholramphenicol aplastic anemia is dose unrelated/related and reversible/irreversible. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cholramphenicol aplastic anemia has an onset of _______. |  | Definition 
 
        | Very delayed, months after dose |  | 
        |  | 
        
        | Term 
 
        | If the onset for Cholramphenicol aplastic anemia is ______ then the patient will survive. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | If the onset for Cholramphenicol aplastic anemia is ______ then the patient will die. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cholramphenicol toxicity can possibly be attributed to its effect on _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cholramphenicol has physical incompatibilities with: __________. |  | Definition 
 
        | TETRACYCLINES POLYMYXIN B V
 ANCOMYCIN
 HYDROCORTISONE
 |  | 
        |  | 
        
        | Term 
 
        | If cephalosporins fail to treat _________, Cholramphenicol can then be used to treat. |  | Definition 
 
        | *SALMONELLA (TYPHOID FEVER |  | 
        |  | 
        
        | Term 
 
        | ****If TETRACYCLINES fail to treat _________ or ________, Cholramphenicol can then be used to treat. |  | Definition 
 
        | *BRUCELLA (BRUCELLOSIS ****RICKETTSIAL DISEASES (RMSF)
 |  | 
        |  | 
        
        | Term 
 
        | If β-LACTAMS fail to treat _________, Cholramphenicol can then be used to treat. |  | Definition 
 
        | *NEISSERIA MENINGITIDIS (Chorl has good CSF levels) |  | 
        |  | 
        
        | Term 
 
        | Cholramphenicol has an antagonist interaction with? |  | Definition 
 
        | CHLORAMPHENICOL + ERYTHROMYCIN (COMPETE FOR 50S SUBUNIT) |  | 
        |  | 
        
        | Term 
 
        | Cholramphenicol has an synergistic interaction with? |  | Definition 
 
        | CHLORAMPHENICOL + PENICILLINS |  | 
        |  | 
        
        | Term 
 
        | Cholramphenicol has an overall drug interaction with other drugs because of its ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | __________ and ________ decrease the half life of Cholramphenicol. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides, Static or Cidal? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides structure? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycoside drugs can be distinguished by their ______ ending. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides disrupt _______ by binding _______. |  | Definition 
 
        | Protein synthesis 
 30S (at 30S/50S interface)
 |  | 
        |  | 
        
        | Term 
 
        | Aminoglycosides mechanisms of action for disrupting protein synthesis: ___________. |  | Definition 
 
        | Block initiation of protein synthesis 
 Block further translation and causing premature termination of the 70S complex
 
 Incorporation of the wrong AA
 |  | 
        |  | 
        
        | Term 
 
        | Aminoglycosides block the initiation of protein synthesis by inhibiting the binding of ______ to _______. |  | Definition 
 
        | *Met-amino-acyl tRNAs to ribosomes |  | 
        |  | 
        
        | Term 
 
        | For Aminoglycosides penetration of the cell wall is dependent upon _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides can get through the ________ using passive transport without Oxygen. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides can get through cell membrane into the cytoplasm using _________ with ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides are not effective against? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Resistance against Aminoglycosides can be gained by a change in _____ structure. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The main mechanism for resistance for Aminoglycosides is __________. |  | Definition 
 
        | ***Acetylation provided by the R factor |  | 
        |  | 
        
        | Term 
 
        | Acetylation of Aminoglycosides results in ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides' absorption? |  | Definition 
 
        | Poor, cannot be administered orally |  | 
        |  | 
        
        | Term 
 
        | Aminoglycosides are administered via? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides CSF concentration? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides metabolism? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides excretion? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides, Static or Cidal? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides structure? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycoside drugs can be distinguished by their ______ ending. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides disrupt _______ by binding _______. |  | Definition 
 
        | Protein synthesis 
 30S (at 30S/50S interface)
 |  | 
        |  | 
        
        | Term 
 
        | Aminoglycosides mechanisms of action for disrupting protein synthesis: ___________. |  | Definition 
 
        | Block initiation of protein synthesis 
 Block further translation and causing premature termination of the 70S complex
 
 Incorporation of the wrong AA
 |  | 
        |  | 
        
        | Term 
 
        | Aminoglycosides block the initiation of protein synthesis by inhibiting the binding of ______ to _______. |  | Definition 
 
        | *Met-amino-acyl tRNAs to ribosomes |  | 
        |  | 
        
        | Term 
 
        | For Aminoglycosides penetration of the cell wall is dependent upon _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides can get through the ________ using passive transport without Oxygen. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides can get through cell membrane into the cytoplasm using _________ with ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides are not effective against? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Resistance against Aminoglycosides can be gained by a change in _____ structure. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The main mechanism for resistance for Aminoglycosides is __________. |  | Definition 
 
        | ***Acetylation provided by the R factor |  | 
        |  | 
        
        | Term 
 
        | Acetylation of Aminoglycosides results in ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides' absorption? |  | Definition 
 
        | Poor, cannot be administered orally |  | 
        |  | 
        
        | Term 
 
        | Aminoglycosides are administered via? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides CSF concentration? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides metabolism? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides excretion? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides, Static or Cidal? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides structure? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycoside drugs can be distinguished by their ______ ending. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides disrupt _______ by binding _______. |  | Definition 
 
        | Protein synthesis 
 30S (at 30S/50S interface)
 |  | 
        |  | 
        
        | Term 
 
        | Aminoglycosides mechanisms of action for disrupting protein synthesis: ___________. |  | Definition 
 
        | Block initiation of protein synthesis 
 Block further translation and causing premature termination of the 70S complex
 
 Incorporation of the wrong AA
 |  | 
        |  | 
        
        | Term 
 
        | Aminoglycosides block the initiation of protein synthesis by inhibiting the binding of ______ to _______. |  | Definition 
 
        | *Met-amino-acyl tRNAs to ribosomes |  | 
        |  | 
        
        | Term 
 
        | For Aminoglycosides penetration of the cell wall is dependent upon _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides can get through the ________ using passive transport without Oxygen. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides can get through cell membrane into the cytoplasm using _________ with ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides are not effective against? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Resistance against Aminoglycosides can be gained by a change in _____ structure. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | The main mechanism for resistance for Aminoglycosides is __________. |  | Definition 
 
        | ***Acetylation provided by the R factor |  | 
        |  | 
        
        | Term 
 
        | Acetylation of Aminoglycosides results in ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides' absorption? |  | Definition 
 
        | Poor, cannot be administered orally |  | 
        |  | 
        
        | Term 
 
        | Aminoglycosides are administered via? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides CSF concentration? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides metabolism? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides excretion? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides' two main toxicities: ________. |  | Definition 
 
        | 1) **8TH CRANIAL NERVE 2) **RENAL DAMAGE
 |  | 
        |  | 
        
        | Term 
 
        | Aminoglycosides' ototoxicity manifests as _______ or ______ damage. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides' ototoxicity Auditory damage manifests as: ___________. |  | Definition 
 
        | TINNITUS HIGH – FREQUENCY HEARING LOSS
 |  | 
        |  | 
        
        | Term 
 
        | Aminoglycosides' ototoxicity Vestibular damage manifests as: ___________. |  | Definition 
 
        | VERTIGO ATAXIA
 LOSS OF BALANCE
 |  | 
        |  | 
        
        | Term 
 
        | Aminoglycosides' ototoxicity  is resultant of damage to ______ and ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What frequency of hearing goes first with  Aminoglycosides' ototoxicity? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides exhibit synergistic ototoxicity with _______. |  | Definition 
 
        | ETHACRYNIC ACID / FUROSEMIDE (LOOP – INHIBITING DIURETICS)
 |  | 
        |  | 
        
        | Term 
 
        | Aminoglycosides cause renal toxicity because _______, which ends up damaging _________. |  | Definition 
 
        | Aminoglycosides get trapped in lyososomes 
 Brush border
 |  | 
        |  | 
        
        | Term 
 
        | Aminoglycosides exhibit synergistic renal toxicity with _______. |  | Definition 
 
        | Any drug that causes renal toxicity... 
 (don't know how impt:
 VANCOMYCIN AMPHOTERTICIN B CEPHALOSPORINS: EXAMPLE KEFLIN POLYMYXIN B)
 |  | 
        |  | 
        
        | Term 
 
        | Aminoglycosides are not to be administered to _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Just as with Tetracyclines, Aminoglycosides have the potential to cause ______ syndrome, which results in _______. |  | Definition 
 
        | Falconi Syndrome (from outdated drugs) 
 Decrease in electrolyte reabsorption
 |  | 
        |  | 
        
        | Term 
 
        | The Aminoglycoside, ___________, can be used to sterilize the bowel, because it ______. |  | Definition 
 
        | Neomycin 
 not absorbed orally
 |  | 
        |  | 
        
        | Term 
 
        | Neomycin is administered _______, because _________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Gentamicin is a ________, it's structure is ________. |  | Definition 
 
        | AG 
 mixture of 3 sugars with 3 R groups
 |  | 
        |  | 
        
        | Term 
 
        | Gentamicin is ineffective in treating _________, because ________. |  | Definition 
 
        | Anaerobes (AGs) 
 need O2 for entry
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Gentamicin is the drug of choice for treating: ___________. |  | Definition 
 
        | *KLEBSIELLA PNEUMONIAE (HOSPITAL - ACQUIRED) 
 *PROTEUS MIRABILIS
 
 **PSEUDOMONAS AERUGINOSA (resistance problem)
 |  | 
        |  | 
        
        | Term 
 
        | Aminoglycosides are used to treat _______ bacteria. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides are used to treat when suspension of _____ in combination with _________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | β – LACTAM + Aminoglycosides has what three effects: ________. |  | Definition 
 
        | Extend coverage to gram + Increase cidal activity
 synerigism
 |  | 
        |  | 
        
        | Term 
 
        | Aminoglycosides + β – LACTAM are used to treat sepsis and _______ and ________ infections. |  | Definition 
 
        | ENTEROCOCAL ENDOCARDITIS 
 STAPHYLOCOCCAL ENDOCARDITIS
 |  | 
        |  | 
        
        | Term 
 
        | *GENTAMICIN + CEPHALOTHIN (KEFLIN® ) = ________ |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | *GENTAMICIN + POLYMYXIN B: = ________ |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | *GENTAMICIN + ETHACRYNIC ACID: = ________ |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Spectinomycin can be used to treat _______  infections in substitute of __________. |  | Definition 
 
        | ACUTE GONOCOCCAL 
 **ALTERNATIVE: IF PENICILLIN ALLERGY / RESISTANCE
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | – LOW RENAL TOXICITY (RARE) – NO OTOTOXICITY
 
 (Low compared to true AGs)
 |  | 
        |  | 
        
        | Term 
 
        | Aminoglycoside, Cidal/Static? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | CHLORAMPHENICOL, Cidal/Static? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | TETRACYCLINES, Cidal/Static? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | TETRACYCLINES, bind _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | SPECTINOMYCIN, bind _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | ERTHYROMYCIN, bind _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | CLINDAMYCIN, bind _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | AMINOGLYCOSIDES, bind _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides have _______-dependent cidal activity. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycoside's toxicity ______ is most critical. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aminoglycosides (specifically Gentamicin) are dosed? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Dosage of Gentamicin (Aminoglycoside) varies with ___________. |  | Definition 
 
        | Renal Clearence (measured by Creatine clearance) 
 Decrease with lower clearance
 |  | 
        |  | 
        
        | Term 
 
        | Streptogramins A & B (________ & ______) |  | Definition 
 
        | Quinupristin & Dalfoprisitin 
 "prisitin "
 |  | 
        |  | 
        
        | Term 
 
        | Streptogramins A & B (Quinupristin & Dalfoprisitin) disrupt _______ by binding to _____. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Streptogramins A & B (Quinupristin & Dalfoprisitin)  mechanism of action is ______. |  | Definition 
 
        | Inhbiting peptidyl transferase |  | 
        |  | 
        
        | Term 
 
        | Streptogramins A & B (Quinupristin & Dalfoprisitin) bind 50S at _______ and therefore _______. |  | Definition 
 
        | different sites on 50S 
 have synergestic effects
 |  | 
        |  | 
        
        | Term 
 
        | Quinupristin & Dalfoprisitin is used to treat __________. |  | Definition 
 
        | **VANCOMYCIN RESISTANT ENTEROCOCCUS FAECIUM |  | 
        |  | 
        
        | Term 
 
        | Quinupristin & Dalfoprisitin is reserved for _____. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Quinupristin & Dalfoprisitin (Streptogramins) drug-drug interaction? |  | Definition 
 
        | Inhibit CYT P450 
 Increase activity of other drugs
 |  | 
        |  | 
        
        | Term 
 
        | Quinupristin & Dalfoprisitin (Streptogramins) toxicity? |  | Definition 
 
        | PHLEBITIS HYPERBILIRUBINEMIA
 |  | 
        |  | 
        
        | Term 
 
        | Oxazoladinones (Linezolid trade name) is used to treat ______ & ______. |  | Definition 
 
        | VANCOMYCIN - RESISTANT E. FAECIUM (VRE) 
 MRSA  VRSA  LRSA
 |  | 
        |  | 
        
        | Term 
 
        | Oxazoladinones (Linezolid trade name) disrupts _______ and binds to _______. |  | Definition 
 
        | Protein synthesis 
 50S at A site
 |  | 
        |  | 
        
        | Term 
 
        | Anti-Fungal Agents, Cell wall inhibitors: ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Anti-Fungal Agents, Cell membrane inhibitors: ______. |  | Definition 
 
        | Polyenes (Nystatin) Azoles
 |  | 
        |  | 
        
        | Term 
 
        | Anti-Fungal Agents, nuclear division inhibitors: ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Anti-Fungal Agents, nucleic acid (DNA/RNA) inhibitors: ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Nystatin is a _________, with a _______ structure, antifungal agent. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Does Nystatin posses antibacterial capabilities? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Nystatin main use is against ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Nystatin mechanism of action: _________. |  | Definition 
 
        | Increase the permeability of the membrane |  | 
        |  | 
        
        | Term 
 
        | Nystatin Increases the permeability of the membrane, which causes the ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | If __________, then the fungus is sensitive to Nystatin |  | Definition 
 
        | There are no sterols in media |  | 
        |  | 
        
        | Term 
 
        | Nystatin has selective binding toxicity with ________, which affects ______ and ______. |  | Definition 
 
        | Lysosomal Membranes 
 RBC hemolysis
 
 Kidney Damage
 |  | 
        |  | 
        
        | Term 
 
        | Nystatin is administered _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Nystatin displays selective binding toxiciity when _______. |  | Definition 
 
        | Administered systemically |  | 
        |  | 
        
        | Term 
 
        | Nystatin is used as an ointment to treat _______ and topically to treat _______ and orally to treat ______. |  | Definition 
 
        | Candida 
 Moniliasis skin
 
 Moniliasis GI
 |  | 
        |  | 
        
        | Term 
 
        | Overall Nystatin is used to treat ______ infections. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Amphotericin B is a _________, with a _______ structure, antifungal agent. |  | Definition 
 
        | Macrolide with a *Polyene |  | 
        |  | 
        
        | Term 
 
        | Amphotericin B binds to ________ causing ________ by ________. |  | Definition 
 
        | Fungal Membranes 
 Ions to leak out
 
 Causing pores to form in the membrane
 |  | 
        |  | 
        
        | Term 
 
        | Amphotericin B has selectivity of action against __________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Amphotericin B is administered ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Amphotericin B toxicity with IV admin? |  | Definition 
 
        | Thrombophlebitis (WIKI inflammation of a vein caused by a blood clot.) |  | 
        |  | 
        
        | Term 
 
        | Plasma Concentration target for Amphotericin B? |  | Definition 
 
        | 2x needed to kill in vitro (vs 4x as with other antibiotics) |  | 
        |  | 
        
        | Term 
 
        | Amphotericin B can be administered to treat _____________, but runs the side effect of developing __________. |  | Definition 
 
        | intrathecally 
 FUNGAL MENINGITIS
 
 CHEMICAL MENINGITIS
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | introduced into or occurring in the space under the arachnoid membrane of the brain or spinal cord |  | 
        |  | 
        
        | Term 
 
        | Amphotericin B's most common, but not most serious, toxicity is _________, resulting from a ________. |  | Definition 
 
        | Anemia 
 Decrease in the production of erythroid proteins
 |  | 
        |  | 
        
        | Term 
 
        | Amphotericin B anemia toxicity is treated with _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Amphotericin B's primary toxicity of concern is ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Amphotericin B's renal toxicity consists of: ____________. |  | Definition 
 
        | Increase BUN Increase Serum Creatine
 Decrease Urea Clearance
 Decrease ability to concentrate
 Deposition of Ca2+ in kindeys
 Renal Tubular Alkalosis
 |  | 
        |  | 
        
        | Term 
 
        | Amphotericin B is dosed _________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Amphotericin B permanent kidney damage occurs when ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Ketoconazole is administered? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Ketoconazole is used to treat _________ infections. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | ***Ketoconazole's main issue is that it __________, which interferes with ________ and ________, leading to _________. |  | Definition 
 
        | Decreases CYT P450 activity 
 Interferes with steroid biosynthesis
 Metabolism of other drugs
 (gyneomastia)
 |  | 
        |  | 
        
        | Term 
 
        | Ketoconazole mechanism of action? |  | Definition 
 
        | Inhibits ergosterol synthesis |  | 
        |  | 
        
        | Term 
 
        | ergosterol is essential for _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Ketoconazole has partially replaced ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Itraconazole mechanism of action? |  | Definition 
 
        | Inhibits ergosterol synthesis |  | 
        |  | 
        
        | Term 
 
        | Itraconazole is related to ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Itraconazole advantage over Ketoconazole? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Voriconazole main advantage, ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Voriconazole is used to treat ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Voriconazole mechanism of action? |  | Definition 
 
        | Inhibits ergosterol synthesis |  | 
        |  | 
        
        | Term 
 
        | Miconazole mechanism of action? |  | Definition 
 
        | Inhibits ergosterol synthesis |  | 
        |  | 
        
        | Term 
 
        | Miconazole is administered _______. |  | Definition 
 
        | Topically, too toxic to be systemically |  | 
        |  | 
        
        | Term 
 
        | Miconazole is used topically to treat _______ and ___________. |  | Definition 
 
        | Candida Albicans (skin and vagina) 
 Tinea (ringworm)
 |  | 
        |  | 
        
        | Term 
 
        | Miconazole is used to treat Tinea (ringworm) which includes: __________. |  | Definition 
 
        | PEDIS (FEET) CRURIS (THIGHS, PERINEUM)
 VESICOLOR (TRUNK)
 |  | 
        |  | 
        
        | Term 
 
        | Which azole has good CSF penetration? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Fluconazole mechanism of action? |  | Definition 
 
        | Inhibits ergosterol synthesis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Teratogenic (SKELETAL / CARDIAC DEFORMITIES) 
 **Rash (AIDS patient)
 Stevens-Johnson Syndrome (AIDS)
 Liver (AIDS)
 Thrombocytopenia (AIDS)
 |  | 
        |  | 
        
        | Term 
 
        | Fluconazole drug drug interaction: ________. |  | Definition 
 
        | * Increase Phenytoin
 Increase Sulfonylureas
 Increase Warfarin
 Increase Cyclosporin
 |  | 
        |  | 
        
        | Term 
 
        | Main issue with Fluconazole usage? |  | Definition 
 
        | *Developing resistance [ ESPECIALLY PROPHYLACTIC USE – TRANSPLANT / AIDS ]
 |  | 
        |  | 
        
        | Term 
 
        | Fluconazole is used to treat: ________. |  | Definition 
 
        | *Oral/Esophageal Candidiasis (AIDS have issues, but still used) 
 *Cryptococcal Meningitis relapse after Amp B administration (Good CSF penetration, but AIDS patient trouble)
 
 Coccidioidal Meningitis (Good CSF Pen)
 |  | 
        |  | 
        
        | Term 
 
        | _________ is the broadest spectrum of all the Azoles? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Griseofulvin mechanism of action? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Griseofulvin is used to treat: _______. |  | Definition 
 
        | Candida Albicans 
 Ringworm:
 Microsporum
 Trichophyton
 Epidermophyton
 |  | 
        |  | 
        
        | Term 
 
        | Griseofulvin route of administration? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Griseofulvin absorption can be increased by? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Griseofulvin treatment duration? |  | Definition 
 
        | 4-6 weeks skin 
 Months for nails
 |  | 
        |  | 
        
        | Term 
 
        | Griseofulvin treats ______ infections of the skin, hair, and nails. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Griseofulvin primary side effect is ________ and has a drug drug interaction with ______, which causes _________. |  | Definition 
 
        | Headache 
 Warfarin, increase its metabolism
 |  | 
        |  | 
        
        | Term 
 
        | Griseofulvin's therapeutic effect is in treating ________ foot and fungal infections of the _____ & ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Griseofulvin is a Cidal/Static agent? |  | Definition 
 
        | Static (why takes so long)) |  | 
        |  | 
        
        | Term 
 
        | Flucytosine undergoes _____ in the fungal cell. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Flucytosine undergoes Lethal synthesis in the fungal cell, converting it from the ______ form, Flucytosine, to the ________ form, ___________. |  | Definition 
 
        | prodrug 
 active/antimetabolite
 
 5-Flurouracil
 |  | 
        |  | 
        
        | Term 
 
        | What does 5-Flurouracil do? |  | Definition 
 
        | Inhibits Thymidylate synthesis disrupting nucleic acid synthesis |  | 
        |  | 
        
        | Term 
 
        | 5-Flurouracil (Flucytosine) is administered? |  | Definition 
 
        | Not as a single drug, but in combination with other drugs bc of resistance |  | 
        |  | 
        
        | Term 
 
        | 5-Flurouracil (Flucytosine) is combined with ______ or ______ because of emerging resistance problems. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 5-Flurouracil (Flucytosine) is used mainly to treat __________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 5-Flurouracil (Flucytosine) admin route? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 5-Flurouracil (Flucytosine) is more toxic in __________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | 5-Flurouracil (Flucytosine)'s main toxicity is _______. |  | Definition 
 
        | **Serious bone marrow depression |  | 
        |  | 
        
        | Term 
 
        | Antifungals can be potentated by being combined with ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Terbinafine ( a Allylamine) mechanism of aciton? |  | Definition 
 
        | Inhibits Squalene epoxidase (part of ergosterol synthesis |  | 
        |  | 
        
        | Term 
 
        | Terbinafine ( a Allylamine) main side effect? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Terbinafine ( a Allylamine) is used to treat _______ & _______? |  | Definition 
 
        | ATHELETE’S FOOT, RINGWORM |  | 
        |  | 
        
        | Term 
 
        | Terbinafine ( a Allylamine) and P450? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | caspoFUNGIN micaFUNGIN
 anidulaFUNGIN
 |  | 
        |  | 
        
        | Term 
 
        | Echinocandins mechanism of action? |  | Definition 
 
        | 1,3- β-GLUCAN SYNTHASE INHIBITORS, which blocks cell wall synthesis |  | 
        |  | 
        
        | Term 
 
        | Caspofungin is used to treat _________. |  | Definition 
 
        | Invasive Aspergillos 
 Mucocutaneous Candidas
 
 Bld Stream Candidas
 |  | 
        |  | 
        
        | Term 
 
        | Micafungin is used to treat __________. |  | Definition 
 
        | Esophageal Candididasis (HIV + Patients)
 |  | 
        |  | 
        
        | Term 
 
        | Anidulafungin is used to treat __________. |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Phenobarbital lowers the serum levels of ________, having an absorption effect. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | **Griseofulvin induces ______ enzymes and leads to a decrease in ___________. |  | Definition 
 
        | Microsomal enzymes 
 Warfarin
 |  | 
        |  | 
        
        | Term 
 
        | **Griseofulvin induces _______ which can cause Porphyria. |  | Definition 
 
        | δ - AMINOLEVULINIC ACID SYNTHETASE |  | 
        |  | 
        
        | Term 
 
        | Major Agents of Anti-TB: ________. |  | Definition 
 
        | INH Rifampin
 Ethambutol
 Pyrazinamide
 Streptomycin
 |  | 
        |  | 
        
        | Term 
 
        | For INH RESISTANCE <4%, TB Drug Regiment: __________. |  | Definition 
 
        | INH Rifampin
 Ethambutol
 Pyrazinamide
 |  | 
        |  | 
        
        | Term 
 
        | For INH RESISTANCE >4%, TB Drug Regiment: __________. |  | Definition 
 
        | Rifampin Ethambutol
 Pyrazinamide
 Fluroquinolone
 |  | 
        |  | 
        
        | Term 
 
        | Have to undergo DRUG REGIMEN (IRPE/S) if you meet any of these criteria: ___________. |  | Definition 
 
        | *PREVIOUS EXPOSURE TO DRUG - RESISTANT TB *ASIANS & HISPANICS IF RECENT IMMIGRANTS
 *MILIARY TB (NODULES & disseminated)
 *TB MENINGITIS
 *EXTENSIVE PULMONARY DISEASE
 *HIV
 |  | 
        |  | 
        
        | Term 
 
        | After treatment for TB, should see results within ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | ______ anti TB drug can be used prophylactically for those ________. |  | Definition 
 
        | Exposed to TB, but no infection + skin test, but no disease
 HIV
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | be cleaved to active form |  | 
        |  | 
        
        | Term 
 
        | Isoniazid, prodrug, is cleaved by _______ into _______, the active form of the drug. |  | Definition 
 
        | Catalase/Peroxidase 
 Isonicotinic Acid
 |  | 
        |  | 
        
        | Term 
 
        | Isonicotinic Acid affects the TB cell by: ________. |  | Definition 
 
        | causing H2O2 to increase and target small molecules (Minor) 
 **Decreasing Mycolic Acid synthesis leading to cell wall synthesis
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Mycobacterium have _____ in their cell walls. |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Isoniazid has a ______ problem. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | ____ % of strains of TB are Isoniazid resistant in US. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Isoniazid resistance is conferred by a mutation in _____ that results in _______. |  | Definition 
 
        | **Catalase, reduced activity |  | 
        |  | 
        
        | Term 
 
        | Isoniazid resistance is conferred by an alteration in biosynthesis of _____ that results in _______. |  | Definition 
 
        | Mycolic acid 
 less inhibition
 |  | 
        |  | 
        
        | Term 
 
        | **Isoniazid is metabolized by _________, which results in ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Isoniazid can be _______ into its active form ISONICOTINIC ACID or it can be ________ into its inactive form. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Metabolism of Isoniazid varies between _______. |  | Definition 
 
        | Fast and slow acetylators |  | 
        |  | 
        
        | Term 
 
        | Fast and slow acetylators is determined by _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Fast acetylators: __________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Acetylator activity is determined by levels of ________ enzyme. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Fast Acetylator genotype is inherited __________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Acetylation activity of Isoniazid affects ________ toxicity. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Isoniazid can cause Pyridoxine Deficiency (especially ______ aceylators), because _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | **Isoniazid's two main toxicities: ___________. |  | Definition 
 
        | Peripheral Neuropathy 
 Hepatic
 |  | 
        |  | 
        
        | Term 
 
        | **Isoniazid's Peripheral Neuropathy toxicity is due to ________ and is treated by __________.
 |  | Definition 
 
        | Isoniazid and B6 structure similarity 
 Supplemental B6 (slow and fast acetyl)
 |  | 
        |  | 
        
        | Term 
 
        | **The hepatotoxicity associated with Isoniazid use risk is increased with ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | **The Isoniazid hepatotoxicity causes __________. |  | Definition 
 
        | Hepatitis (liver necrosis) |  | 
        |  | 
        
        | Term 
 
        | *When administering Isoniazid, especially to _______, ________ needs to be monitored, especially if being taken with ______.. |  | Definition 
 
        | children 
 Liver function tests
 
 Rifampin
 |  | 
        |  | 
        
        | Term 
 
        | INH is the only drug used for _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Ethambutol is a ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Ethambutol mechanism of action: _______. |  | Definition 
 
        | Inhibits Arabinosyl transferase (Cell wall inhibitor) |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Ethambutol's main toxicity? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Ethambutol's main toxicity, Retrobulbar Neuritis, manifests as ________. |  | Definition 
 
        | Loss of visual acuity Red Green color blindness
 |  | 
        |  | 
        
        | Term 
 
        | Before giving Ethambutol you must? |  | Definition 
 
        | Test visual acuity and color blindness |  | 
        |  | 
        
        | Term 
 
        | Rifampin is a ______ anti TB agent. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | *Rifampin is used to treat: ______. |  | Definition 
 
        | Systemic TB TB Meninigitis
 MENINGOCOCCAL carrier state (cause of meningitis)
 |  | 
        |  | 
        
        | Term 
 
        | Rifampin binds to _______ and blocks ________. |  | Definition 
 
        | DNA dependent RNA Pol 
 Transcription of RNA
 |  | 
        |  | 
        
        | Term 
 
        | **Rifampin has no effect on __________. |  | Definition 
 
        | Mammalian DNA dependent RNA Pol |  | 
        |  | 
        
        | Term 
 
        | Rifampin resistance comes from a mutation in _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Rifampin has very good distribution especially _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Rifampin toxicity overall is? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Rifampin Main toxicities: __________. |  | Definition 
 
        | ***Hepatitis (rare, 1/30,000 have to worry when combined with INH) 
 **Orange stain teats/sweat (contacts)
 
 **Flu like symptoms
 |  | 
        |  | 
        
        | Term 
 
        | Rifampin is used to treat: __________. |  | Definition 
 
        | **Active TB 
 **Meningococcal
 
 **TB meningitis
 
 M. leprae
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mycobacterium (leprae/TB) 
 Some gram +
 |  | 
        |  | 
        
        | Term 
 
        | Rifampin's main drug drug interaction is __________, because it is a _____________. |  | Definition 
 
        | Decrease the half life of other drugs *Oral contraceptives (double whammy bc also kills the bacteria used to regen)
 
 Potent inducer of liver microsomal enzymes
 |  | 
        |  | 
        
        | Term 
 
        | Pyrazinamide, primary or secondary? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Pyrazinamide mechanism of action? |  | Definition 
 
        | Lowers pH leading to no growth for mycobacteria 
 Disrupt mycolic acid
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Pyrazinamide main toxicity? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Because of Pyrazinamide's liver toxicity you must _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Pyrazinamide toxicity is ______. |  | Definition 
 
        | Tolerable for short durations |  | 
        |  | 
        
        | Term 
 
        | Streptomycin, primary or secondary? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Streptomycin main toxicities? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Streptomycin class of drugs? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cycloserine primary or secondary? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cycloserine MOA: _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cycloserine main toxicities: ____________. |  | Definition 
 
        | *Periph Neuropathy 
 *CNS dysfunction (depression etc.)
 
 *Grand MAL/ Petit MAL convulsions (seizures), especially when combined with ALCOHOL*
 |  | 
        |  | 
        
        | Term 
 
        | Cycloserine is not recommend for: _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cycloserine is administered with _______ in order to __________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Ethionamide is a ______ drug. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Ethionamide main toxicities: ________. |  | Definition 
 
        | *GI *Depression
 *Neurological (vision)
 |  | 
        |  | 
        
        | Term 
 
        | Capreomycin is a ______ drug and _____ chemical class. |  | Definition 
 
        | Secondary AntiTB 
 Cyclic Peptide
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Kanamycin is a ______ drug and _____ chemical class. |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Which secondary AntiTB agent is rarely used? |  | Definition 
 
        | Aminosalicylic Acid (PAS) |  | 
        |  | 
        
        | Term 
 
        | Aminosalicylic Acid (PAS) is rarely used as secondary AntiTB agent because of its ________. |  | Definition 
 
        | ***GI problems 
 ***Compliance (won't take bc of GI problems)
 
 *Hypersensitivity
 |  | 
        |  | 
        
        | Term 
 
        | Aminosalicylic Acid (PAS) MOA: ________. |  | Definition 
 
        | Inhibits coupling enzyme, disrupting Folic acid synthesis |  | 
        |  | 
        
        | Term 
 
        | ______ + _______ increases hepatoxicity for AntiTB drugs. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | ______ + _______ causes absorption problems for AntiTB drugs |  | Definition 
 
        | Rifampin + Aminosalicylic Acid (PAS) |  | 
        |  | 
        
        | Term 
 
        | ______ antiTB agent interferes with oral contraceptives use. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | _______ antiTB agent induces _________ leading to a ________ for other drugs, especially _________. |  | Definition 
 
        | *Rifampin 
 Liver microsomal enzymes
 
 decrease in T1/2
 
 Oral contraceptives
 |  | 
        |  | 
        
        | Term 
 
        | **Dapsone is a _______ drug. |  | Definition 
 
        | Anti-Leprosay (Hansen's Disease) |  | 
        |  | 
        
        | Term 
 
        | Dapsone is related to _____ drugs. |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | *Inhibits Folic Acid Synthesis 
 *Competes with PABA
 |  | 
        |  | 
        
        | Term 
 
        | Dapsone Toxicities: __________. |  | Definition 
 
        | GI 
 Blood Dyscrasis (Hemolytic anemia & Methemoglobinenmia)
 |  | 
        |  | 
        
        | Term 
 
        | Dapsone causes Hemolytic anemia in ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Dapsone causes Methemoglobinenmia by __________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Anti-Leprosay is accomplished through ______ drug therapy. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | _______ Anti-Leprosay drug is not used anymore because of it causing the birth defect _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Anti-Leprosay treatment minimum time frame ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | MYCOBACTERIUM AVIUM COMPLEX is treated using ______ drug therapy. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Most common species of Plasmodium? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Most lethal species of Plasmodium? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | P. Falciparum fever pattern? |  | Definition 
 
        | Quotidian (Every day) or *Irregular |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tertain 
 (EVERY OTHER, 3RD DAY)
 |  | 
        |  | 
        
        | Term 
 
        | P. Malariae ever pattern? |  | Definition 
 
        | Quartan (EVERY 3 DAYS) 4TH DAY
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tertain 
 (EVERY OTHER, 3RD DAY)
 |  | 
        |  | 
        
        | Term 
 
        | P. Falciparum causes ______ Tertain malaria. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Liver dormant capable Plasmodium: ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | **Strictly erythrocyte form plasmoidum: ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | P. Falciparum & P. Malariae, how many cycles of liver invasion? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | P. Vivax & P. Ovale can relapse between blood and liver, what is the term for this? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Chloroquine is a ________ class of drug  that targets ________ form. |  | Definition 
 
        | 4-Aminoquinolones 
 BLOOD SCHIZONTICIDE
 
 Blood
 |  | 
        |  | 
        
        | Term 
 
        | 4-Aminoquinolone class MOA: ____________. |  | Definition 
 
        | Inhibits DNA synthesis by intercalating 
 Build up free heme
 |  | 
        |  | 
        
        | Term 
 
        | Chloroquine toxicity: _______. |  | Definition 
 
        | *Ocular toxic Excreted in tears and reabsorbed by cornea
 
 **Cardiac
 Hypotension/Arrest
 
 **RBC Hemolytic Anemia
 |  | 
        |  | 
        
        | Term 
 
        | Chloroquine has a low _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Chloroquine is contradicted for: ___________. |  | Definition 
 
        | **Retinal/Visual abnormalities 
 **Alcoholism
 
 **Neurological Disorders (epilipsy)
 
 ***Hematologic Disorders (G6PDH Defic)
 |  | 
        |  | 
        
        | Term 
 
        | Chloroquine targets _____ forms. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Chloroquine is uses: __________. |  | Definition 
 
        | *Suppressive Prophylatic 
 **8Terminates the acute attacks and cures Falciparum/Malariae
 
 ****Terminates acute attack, no cure Vivax/Ovale
 |  | 
        |  | 
        
        | Term 
 
        | Chloroquine is not effective against _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Chloroquine *Suppressive Prophylatic treatment schedule? |  | Definition 
 
        | 500mg/weekly 3 weeks before during and 3 weeks after |  | 
        |  | 
        
        | Term 
 
        | Amodiaquine is a _______ class of drugs. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Amodiaquine is similar to _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Unlike Amodiaquine is not used _______. |  | Definition 
 
        | for Suppressive Prophylatic |  | 
        |  | 
        
        | Term 
 
        | Why is Amodiaquine not used for Suppressive Prophylaxis? |  | Definition 
 
        | Toxicity increases with long term use |  | 
        |  | 
        
        | Term 
 
        | Chloroquine MOA: __________ |  | Definition 
 
        | (4-Aminoquinolone) Inhibits DNA synthesis by intercalating
 
 Build up free heme
 |  | 
        |  | 
        
        | Term 
 
        | Amodiaquine MOA: __________ |  | Definition 
 
        | (4-Aminoquinolone) Inhibits DNA synthesis by intercalating
 
 Build up free heme
 |  | 
        |  | 
        
        | Term 
 
        | Artemisinin is used to treat _______. |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Heme iron damage/ Alkylation |  | 
        |  | 
        
        | Term 
 
        | Artemisinin is used ________. |  | Definition 
 
        | in combination, because of resistance concern |  | 
        |  | 
        
        | Term 
 
        | Artemisinin is used in combination with |  | Definition 
 
        | CHLOROQUINE / AMODIAQUINE SOME/ MEFLOQUINE
 |  | 
        |  | 
        
        | Term 
 
        | Mefloquine is a _______ class of drug. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Mefloquine targets the _______ forms. |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | **Prophylaxis + Treatment of Chloroquine-resistant and multi-resistant Falciiparum 
 (Chloroquine is usually used for propholyatic)
 |  | 
        |  | 
        
        | Term 
 
        | Mefloquine is propholyatic against? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Mefloquine is contradicted in: _______. |  | Definition 
 
        | People with epilipsy Mood disorders (causes risk of suicide/weird dreams)
 Cardiac Conditions (exacerbates them)
 |  | 
        |  | 
        
        | Term 
 
        | Quinine targets _____ forms. |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Quinine is a _______ Schizonticide for _______ parasites. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Quinine kills the gametophytes of __________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Quinine is/isn't effective against liver forms? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | **Cinchonism (overdose of Quinine) 
 **Blackwater Fever
 |  | 
        |  | 
        
        | Term 
 
        | **Cinchonism (overdose of Quinine) manifests with: ___________. |  | Definition 
 
        | Ototoxic GI Toxicity
 Visual Toxicity (retinal toxicity, blindness)
 |  | 
        |  | 
        
        | Term 
 
        | In addition to Cinchonism, Quinine can be toxic by causing _______, especially dangerous for __________. |  | Definition 
 
        | *Hypoglycemia 
 Pregnant women
 |  | 
        |  | 
        
        | Term 
 
        | Quinine **Blackwater Fever has a ______% fatality rate. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Quinine **Blackwater Fever manifests itself: ____________. |  | Definition 
 
        | Hemolysis Renal Failure
 G6PDH Deficiency
 |  | 
        |  | 
        
        | Term 
 
        | Quinine is contradicted for: ________. |  | Definition 
 
        | G6PDH Deficiency History of: Tinnitus, optic neuritis, myasthenia gravis
 |  | 
        |  | 
        
        | Term 
 
        | Quinine main use it to treat ______. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Quinine can also be used to treat Falciparum that is _______ resistant. |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Quinidine is more potent/toxic |  | 
        |  | 
        
        | Term 
 
        | Primaquine is ______ class of drug. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Primaquine is used to treat ______ form. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Primaquine is a _______ Schizonticide. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | ****Primaquine can be combined with _______ to be used as a radical cure for _______. |  | Definition 
 
        | Chloroquine (get RBC form) 
 Vivax/ Ovale
 |  | 
        |  | 
        
        | Term 
 
        | Primaquine is the primary _______ treatment. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Primaquine Toxicity: ________. |  | Definition 
 
        | ** Hemolytic Anemia (G6PDH)
 Methemoglobinemia (G6PDH)
 |  | 
        |  | 
        
        | Term 
 
        | ______, _______, & __________ anti malarial agents that affect individuals with G6PDH deficiency. |  | Definition 
 
        | Primaquine Quinine
 Chloraquine
 |  | 
        |  | 
        
        | Term 
 
        | Anti-folate anti-malaria drugs: ________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Biguanide must __________. |  | Definition 
 
        | be metabolized in the liver from its pro form to active drug, dihydrotriazine |  | 
        |  | 
        
        | Term 
 
        | Anti bacterial small molecule antifolate, __________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Primethamine MOA: ________. |  | Definition 
 
        | Inhibits Dihydrofolate reductase |  | 
        |  | 
        
        | Term 
 
        | Malaria can also be treated by ______ drugs which are also anti-bacterial. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Sulfanomides MOA: _________. |  | Definition 
 
        | Compete with PABA and inhibit the Coupling Enzyme (Dihydropteroate Synthase) |  | 
        |  | 
        
        | Term 
 
        | Sulfanomides are _____ acting Anti-Malaria drugs. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Atovaquone-Proguanil is used for _________. |  | Definition 
 
        | PROPHYLAXIS / TREATMENT of Chloroquine resistant Falciparum |  | 
        |  | 
        
        | Term 
 
        | Atovaquone-Proguanil MOA: _________. |  | Definition 
 
        | Inhibits MT Electron Transport 
 Inhibits Folate Reductase
 |  | 
        |  | 
        
        | Term 
 
        | Babesiosis is a rare severe ___________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Babesiosis affects __________. |  | Definition 
 
        | Elderly/Immunocompromised |  | 
        |  | 
        
        | Term 
 
        | Babesiosis manifests: __________. |  | Definition 
 
        | Fever and *Hemolytic Anemia |  | 
        |  | 
        
        | Term 
 
        | Babesiosis is treated with: __________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Babesiosis is treated with Quinine and Clindamycin, MOA? |  | Definition 
 
        | Quinine: Inhibit DNA synthesis and Heme buildup 
 Clindamycin: inhibits translocation
 |  | 
        |  | 
        
        | Term 
 
        | Amebicide that is a tissue and luminal (not reliable)? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Metronidazole is a _____ drug and is _________. |  | Definition 
 
        | Prodrug 
 activated in anaerobic conditions
 |  | 
        |  | 
        
        | Term 
 
        | Metronidazole is used to treat: _______. |  | Definition 
 
        | Ameba, Giardia, Trichomonas 
 Anaerobic Bacteria
 |  | 
        |  | 
        
        | Term 
 
        | Indirect acting Luminal Amebicides: ___________. |  | Definition 
 
        | (affect the bacteria supporting it) TETRACYCLINES
 ERYTHROMYCIN
 PAROMOMYCIN (also direct)
 |  | 
        |  | 
        
        | Term 
 
        | Direct acting Luminal Amebicides: ___________. |  | Definition 
 
        | DIIODOHYDROXYQUIN PAROMOMYCIN (also indirect)
 DILOXANIDE FUROATE
 |  | 
        |  | 
        
        | Term 
 
        | Tissue Amebicides: ___________. |  | Definition 
 
        | EMETINE / DEHYDROEMETIN Chloroquine
 |  | 
        |  | 
        
        | Term 
 
        | EMETINE / DEHYDROEMETIN toxicity? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Melarsoprol is used to treat: _______. |  | Definition 
 
        | African Sleeping Sickeness |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Why is Melarsoprol so neurotoxic? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Pentamidine is used to treat: ____________. |  | Definition 
 
        | Pneumocycstis Jiroveci (AIDS) Trypansomes (sleeping sickness)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Severe hyptoension if IV too quickly |  | 
        |  | 
        
        | Term 
 
        | SODIUM Stibogluconate used to treat? |  | Definition 
 
        | LEISHMANIASIS (TRANSMITTED BY SANDFLY) |  | 
        |  | 
        
        | Term 
 
        | SODIUM Stibogluconate toxicity? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Nifurtimox/Benznidazole used to treat? |  | Definition 
 
        | CHAGA’S DISEASE (TRYPANOSOMIASIS) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | **Metronidazole, NITAZOXANIDE 
 TINIDAZOLE less toxicity
 |  | 
        |  | 
        
        | Term 
 
        | Vaginal TRICHOMONIASIS Treatment? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Thiabendazole is used to treat? |  | Definition 
 
        | *Trichinella (Raw pork/beef) NEMATODES
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhibiting Fumarate Reductase |  | 
        |  | 
        
        | Term 
 
        | Albendazole is used to treat? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhibiting Fumarate Reductase |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Broad spectrum of NEMATODES |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Impairs GLC uptake by nematode leading to its paralysis |  | 
        |  | 
        
        | Term 
 
        | Ascaris + Hookworms treated with? |  | Definition 
 
        | Mebendazole or Albendazole |  | 
        |  | 
        
        | Term 
 
        | Thiabendazole is being replaced by? |  | Definition 
 
        | Mebendazole & Albendazole |  | 
        |  | 
        
        | Term 
 
        | Praziquantal is used to treat? |  | Definition 
 
        | ****Schistosomiasis and Liver Flukes 
 Broad spectrum
 |  | 
        |  | 
        
        | Term 
 
        | Praziquantal MOA: __________. |  | Definition 
 
        | Increases permability, causing influx of Ca2+, Paralysis of Fluke |  | 
        |  | 
        
        | Term 
 
        | Praziquantal is not to be used by __________. |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Praziquantal cross problem: __________. |  | Definition 
 
        | Ocular Cysticercosis (pork tapeworm) 
 kill tapeworm in eye -> ocular lesions
 |  | 
        |  |